PALO ALTO VETERANS INSTITUTE FOR RESEARCH
Cite this
Plain text PALO ALTO VETERANS INSTITUTE FOR RESEARCH. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/770207331. Retrieved 2026-10-21.
APA furp.org. (n.d.). PALO ALTO VETERANS INSTITUTE FOR RESEARCH [Nonprofit organization profile; tax years 2009–2024]. Retrieved October 21, 2026, from https://furp.org/org/770207331
MLA “PALO ALTO VETERANS INSTITUTE FOR RESEARCH.” furp.org, tax years 2009–2024, https://furp.org/org/770207331. Accessed 21 Oct. 2026.
Retrieved 2026-10-21; covers tax years 2009–2024. Data: furp.org, CC BY 4.0.
2024 · Form 990 · revenue $35.9M · expenses $33.0M · assets $19.1M
- Also known as
- PAVIR
- EIN
- 77-0207331
- Address
- 3801 MIRANDA AVE, PALO ALTO, CA 94304-1207
- Website
- WWW.PAVIR.ORG
- NTEE code
- H00E
- Subsection
- 501(c)(3)
- Ruling year
- 1996
- Cross-check
- ProPublica Nonprofit Explorer
Mission
PAVIR'S MISSION IS ADVANCING VETERANS AND PUBLIC HEALTH THROUGH INNOVATIVE RESEARCH. PAVIR WORKS WITH MORE THAN 100 PRINCIPAL INVESTIGATORS AND 200 RESEARCH STAFF TO SUPPORT BASIC SCIENCE, CLINICAL AND HEALTH SERVICES RESEARCH TO REALIZE ITS MISSION. PAVIR'S DIVERSE STUDIES SPAN THE ENTIRE SPECTRUM OF HEALTH RESEARCH FROM THE INVESTIGATION OF DISEASES IN THE LABORATORY THROUGH TESTING NEW DRUG TREATMENTS AND DEVELOPING IMPROVED MODELS OF HEALTH CARE DELIVERY TO LOOKING AT OUTCOMES BOTH INDIVIDUALLY AND ON A LARGE SCALE. PAVIR'S RESEARCH ADDRESSES HEALTH CHALLENGES THAT HAVE BEEN FACED ESPECIALLY BY VETERANS, INCLUDING POST-TRAUMATIC STRESS DISORDER, TRAUMATIC BRAIN INJURY, GERIATRIC MEDICINE, REHABILITATION, SLEEP AND OTHER VETERANS AND PUBLIC HEALTH ISSUES. PAVIR'S INVESTIGATORS HAVE APPOINTMENTS AT THE VA PALO ALTO HEALTH CARE SYSTEM AND MOST ALSO HOLD APPOINTMENTS AT THE STANFORD UNIVERSITY SCHOOL OF MEDICINE.
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
37 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Mary Thornton | DIRECTOR OF OPERATIONS | 2009-2024 | $226,841 | $2,370,570 | 1 |
| Lily Ibragimov | DIRECTOR OF FINANCE & ACCOUNTING | 2010-2024 | $216,193 | $2,139,872 | 1 |
| Elaine Staats | CHIEF EXECUTIVE OFFICER | 2011-2024 | $346,209 | $2,015,132 | 1 |
| Stephanie Hensey | DEVELOPER / DATABASE ADMINISTRATOR | 2009-2024 | $185,032 | $1,410,645 | 1 |
| Lisa Clark | DIRECTOR OF HUMAN RESOURCES | 2019-2024 | $215,758 | $1,173,615 | 1 |
| Xinguo Jiang | RESEARCH SCIENTIST II | 2016-2024 | $202,103 | $1,070,335 | 1 |
| Allison Malate | DIRECTOR OF SPONSORED RESEARCH | 2022-2024 | $222,006 | $613,971 | 1 |
| Calvert Lee | SR. CLINICAL RESEARCH MANAGER | 2022-2024 | $197,255 | $566,414 | 1 |
| Maheen Adamson | DIRECTOR | 2018-2024 | $0 | $473,556 | 1 |
| Timothy Myles | RESEARCH SCIENTIST III | 2024 | $227,354 | $227,354 | 1 |
| Nora Thomas | HUMAN RESOURCES MANAGER | 2024 | $178,712 | $178,712 | 1 |
| Jian Luo | RESEARCH SCIENTIST III | 2024 | $173,333 | $173,333 | 1 |
| Kerstin Lynam (former) | CEO THRU 11/14/17 | 2013-2017 | $301,918 | $1,287,832 | 1 |
| Michael Anthony Hindery (former) | CEO thru 9/1/21 | 2017-2021 | $248,925 | $1,108,390 | 1 |
| Wen Amy Tian (former) | Research Scientist | 2015-2021 | $162,720 | $1,047,037 | 1 |
| Bonnie Oiking Liang (former) | CFO/COO UNTIL 06/30/19 | 2015-2019 | $160,103 | $956,484 | 1 |
| Donna Mccartney (former) | EXECUTIVE DIRECTOR | 2009-2013 | $180,461 | $806,245 | 1 |
| Brian Doherty (former) | IT MANAGER | 2009-2014 | $151,650 | $705,212 | 1 |
| Patricia Grice (former) | CFO | 2009-2011 | $148,839 | $422,215 | 1 |
| Jenny Nhu-Thuy Dao (former) | Accounting Manager | 2022-2023 | $184,496 | $354,509 | 1 |
| Junliang Pan (former) | Research Scientist II | 2017-2022 | $145,326 | $281,848 | 1 |
| Michelle Hernandez (former) | HR DIRECTOR (Thru 02/2016) | 2014-2015 | $141,625 | $278,594 | 1 |
| Mary Mcelrath (former) | NURSE COORDINATOR | 2009-2010 | $119,460 | $247,581 | 1 |
| Ferid Murad (former) | Director to 1/24/23 | 2016-2022 | $0 | $237,440 | 1 |
| Mary Thornton Thru 53115 (former) | COO | 2014 | $178,890 | $178,890 | 1 |
| Kevin Chow (former) | System Administrator II | 2023 | $178,669 | $178,669 | 1 |
| Stephany Hensey (former) | DATABASE ADMINISTRATOR | 2014 | $159,619 | $159,619 | 1 |
| Jennifer J Crockett (former) | Assoc Dir of Research Administration | 2021 | $153,572 | $153,572 | 1 |
| Cuiping Pan (former) | BUSINESS DEVELOPMENT MANAGER III | 2020 | $151,310 | $151,310 | 1 |
| John Haber (former) | PRINCIPAL INVESTIGATOR | 2011 | $131,496 | $131,496 | 1 |
| Irina Gorodetskaya (former) | PROGRAM MANAGER I | 2014 | $130,388 | $130,388 | 1 |
| Maurino Albenetyh (former) | PURCHASING MANAGER | 2013 | $127,960 | $127,960 | 1 |
| Brian Zabel (former) | RESEARCH SCIENTIST | 2013 | $125,871 | $125,871 | 1 |
| Kevin Mcgill (former) | BIOMEDICAL ENGINEER | 2009 | $122,349 | $122,349 | 1 |
| Virginia C Wong (former) | former HR DIRECTOR | 2009 | $120,318 | $120,318 | 1 |
| Rudolf Moos (former) | PRINCIPAL INVESTIGATOR | 2011 | $116,806 | $116,806 | 1 |
| Christos Constantinou (former) | PRINCIPAL INVESTIGATOR | 2010 | $113,289 | $113,289 | 1 |
Officers and directors, no compensation reported
40 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Odette Harris | DIRECTOR / BOARD CHAIR | 2015-2024 | 1 | $0 reported | 1 |
| Paul Heidenreich | DIRECTOR / SECRETARY & TREASURER | 2019-2024 | 0 | $0 reported | 1 |
| Ngan Huang | DIRECTOR | 2022-2024 | 0 | $0 reported | 1 |
| Meghan Kemnec | STATUTORY NON-VA DIRECTOR | 2021-2024 | 0 | $0 reported | 1 |
| Mike Kozal | STATUTORY VA DIRECTOR (THRU 10/2024) | 2020-2024 | 0 | $0 reported | 1 |
| Ware Kuschner | DIRECTOR | 2022-2024 | 0 | $0 reported | 1 |
| Jennifer Lee | STATUTORY VA DIRECTOR | 2018-2024 | 0 | $0 reported | 1 |
| Lawrence Leung | DIRECTOR / AUDIT COMMITTEE CHAIR | 2009-2024 | 0 | $0 reported | 1 |
| Payam Massaband | STATUTORY VA DIRECTOR | 2021-2024 | 0 | $0 reported | 1 |
| Jean Gurga | STATUTORY VA DIRECTOR | 2022-2024 | 0 | $0 reported | 1 |
| Robert Sloss | STATUTORY NON-VA DIRECTOR | 2016-2024 | 0 | $0 reported | 1 |
| Jon Fuller | STATUTORY VA DIRECTOR | 2024 | 0 | $0 reported | 1 |
| Vanessa Ridley | DIRECTOR | 2024 | 0 | $0 reported | 1 |
| Philip Tsao (former) | Director to 9/30/24 | 2011-2023 | 0 | $0 reported | 1 |
| Andrew R Hoffman (former) | Director to 12/26/22 | 2020-2022 | 0 | $0 reported | 1 |
| Lisa Howard (former) | Statutory VA Director to 3/31/23 | 2020-2022 | 0 | $0 reported | 1 |
| Mark Nicolls (former) | Director to 6/10/23 | 2013-2022 | 0 | $0 reported | 1 |
| David J Clark (former) | Director until 8/31/22 | 2009-2021 | 0 | $0 reported | 1 |
| John Pollard (former) | Statutory VA Director until 7/14/22 | 2009-2021 | 0 | $0 reported | 1 |
| Meghan Kemnec Nd (former) | STATUTORY NON-VA DIRECTOR | 2020 | 0 | $0 reported | 1 |
| Thomas J Fitzgerald Iii (former) | STATUTORY VA DIRECTOR UNTIL 1/31/21 | 2015-2020 | 0 | $0 reported | 1 |
| Rina N Shah (former) | STATUTORY VA DIRECTOR UNTIL 2/28/21 | 2019-2020 | 0 | $0 reported | 1 |
| Charlie Conz (former) | STATUTORY NON-VA DIR. UNTIL 01/13/21 | 2015-2020 | 0 | $0 reported | 1 |
| Mary K Goldstein (former) | DIRECTOR UNTIL 05/22/20 | 2016-2019 | 0 | $0 reported | 1 |
| Phillip L Jelsma (former) | Director through 7/26/2017 | 2013-2016 | 0 | $0 reported | 1 |
| Lawrence Leung Statutory Va (former) | DIRECTOR, SECRETARY/TREASURER | 2014-2015 | 1 | $0 reported | 1 |
| PHILIP TSAO Statutory VA (former) | DIRector, CHAIR OF AUDIT Committee | 2015 | 1 | $0 reported | 1 |
| John Pollard Statutory Va (former) | DIRECTOR, AUDIT Committee MEMBER | 2014-2015 | 0 | $0 reported | 1 |
| Elizabeth Joyce Freeman (former) | Statutory VA DIRECTOR (Thru 06/2016) | 2009-2015 | 0 | $0 reported | 1 |
| Carol Olson (former) | DIRECTOR (Thru 06/2016) | 2009-2015 | 0 | $0 reported | 1 |
| Odette Harris Since 92315 (former) | DIRECTOR | 2014 | 0 | $0 reported | 1 |
| Charlie Conz Since 11415 (former) | DIRECTOR | 2014 | 0 | $0 reported | 1 |
| Roberta Oka Thru 083115 (former) | DIRECTOR | 2014 | 0 | $0 reported | 1 |
| Barclay Kamb Thru 092615 (former) | STATUTORY NON-FEDERAL DIRECTOR | 2014 | 0 | $0 reported | 1 |
| Mark Nicolls Since 7215 (former) | DIRECTOR, BOARD CHAIR | 2014 | 1 | $0 reported | 1 |
| Bonnie Liang Since 7815 (former) | CFO | 2014 | 40 | $0 reported | 1 |
| Thomas Rando (former) | DIRECTOR (THROUGH 6/11/14) | 2009-2013 | 1 | $0 reported | 1 |
| Barclay Kamb (former) | STATUTORY NON-FEDERAL DIRECTOR | 2009-2013 | 0 | $0 reported | 1 |
| Roberta Oka (former) | DIRECTOR | 2013 | 0 | $0 reported | 1 |
| Douglas Owens (former) | DIRECTOR | 2009-2011 | 0 | $0 reported | 1 |
People by year
2024 · 25 people listed · 11 paid, $2.4M · 203 employees · 7 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ELAINE STAATS | CHIEF EXECUTIVE OFFICER | 40 | $282,965 | $0 | $63,244 | $346,209 | 1 |
| TIMOTHY MYLES | RESEARCH SCIENTIST III | 40 | $185,636 | $0 | $41,718 | $227,354 | 1 |
| MARY THORNTON | DIRECTOR OF OPERATIONS | 40 | $194,444 | $0 | $32,397 | $226,841 | 1 |
| ALLISON MALATE | DIRECTOR OF SPONSORED RESEARCH | 40 | $190,624 | $0 | $31,382 | $222,006 | 1 |
| LILY IBRAGIMOV | DIRECTOR OF FINANCE & ACCOUNTING | 40 | $185,095 | $0 | $31,098 | $216,193 | 1 |
| LISA CLARK | DIRECTOR OF HUMAN RESOURCES | 40 | $197,306 | $0 | $18,452 | $215,758 | 1 |
| XINGUO JIANG | RESEARCH SCIENTIST II | 40 | $160,856 | $0 | $41,247 | $202,103 | 1 |
| CALVERT LEE | SR. CLINICAL RESEARCH MANAGER | 40 | $155,791 | $0 | $41,464 | $197,255 | 1 |
| STEPHANIE HENSEY | DEVELOPER / DATABASE ADMINISTRATOR | 40 | $158,718 | $0 | $26,314 | $185,032 | 1 |
| NORA THOMAS | HUMAN RESOURCES MANAGER | 40 | $151,316 | $0 | $27,396 | $178,712 | 1 |
| JIAN LUO | RESEARCH SCIENTIST III | 40 | $158,648 | $0 | $14,685 | $173,333 | 1 |
| ODETTE HARRIS | DIRECTOR / BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL HEIDENREICH | DIRECTOR / SECRETARY & TREASURER | 0 | $0 | $0 | $0 | $0 | 1 |
| MAHEEN ADAMSON | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JON FULLER | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JEAN GURGA | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| NGAN HUANG | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MEGHAN KEMNEC | STATUTORY NON-VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MIKE KOZAL | STATUTORY VA DIRECTOR (THRU 10/2024) | 0 | $0 | $0 | $0 | $0 | 1 |
| WARE KUSCHNER | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER LEE | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | DIRECTOR / AUDIT COMMITTEE CHAIR | 0 | $0 | $0 | $0 | $0 | 1 |
| PAYAM MASSABAND | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| VANESSA RIDLEY | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SLOSS | STATUTORY NON-VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2023 · 23 people listed · 10 paid, $2.1M · 248 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Elaine Staats | CEO | 40 | $268,411 | $0 | $64,472 | $332,883 | 1 |
| Mary L Thornton | Director of Operations | 40 | $181,211 | $0 | $32,236 | $213,447 | 1 |
| Lily Ibragimov | Director of Finance & Accounting | 40 | $177,437 | $0 | $31,877 | $209,314 | 1 |
| Lisa Clark | HR Director | 40 | $191,158 | $0 | $17,864 | $209,022 | 1 |
| Allison Malate | Associate Director of Sponsored Research | 40 | $173,275 | $0 | $30,957 | $204,232 | 1 |
| Xinguo Jiang | Research Scientist II | 40 | $153,445 | $0 | $47,503 | $200,948 | 1 |
| Calvert Lee | Clinical Research Manager | 40 | $149,154 | $0 | $42,217 | $191,371 | 1 |
| Jenny Nhu-Thuy Dao | Accounting Manager | 40 | $140,647 | $0 | $43,849 | $184,496 | 1 |
| Stephanie L Hensey | Data Base Analyst II | 40 | $147,124 | $0 | $31,608 | $178,732 | 1 |
| Kevin Chow | System Administrator II | 40 | $133,512 | $0 | $45,157 | $178,669 | 1 |
| Odette Harris | Director, Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Paul Heidenreich | Director, Secretary/Treasurer | 0 | $0 | $0 | $0 | $0 | 1 |
| Maheen Adamson | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Ngan Huang | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Meghan Kemnec | Statutory non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Mike Kozal | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Ware Kuschner | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Jennifer Lee | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Lawrence Leung | Director, Audit Committee Chair | 0 | $0 | $0 | $0 | $0 | 1 |
| Payam Massaband | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Jean Gurga | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert Sloss | Statutory non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Philip Tsao | Director to 9/30/24 | 0 | $0 | $0 | $0 | $0 | 1 |
2022 · 27 people listed · 10 paid, $1.9M · 248 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Elaine Staats | CEO | 40 | $255,786 | $0 | $48,342 | $304,128 | 1 |
| Lisa Clark | HR Director | 40 | $181,477 | $0 | $17,293 | $198,770 | 1 |
| Lily Ibragimov | Director of Finance & Accounting | 40 | $168,662 | $0 | $28,738 | $197,400 | 1 |
| Mary L Thornton | Director of Operations | 40 | $167,635 | $0 | $28,644 | $196,279 | 1 |
| Allison Malate | Associate Director of Sponsored Research | 40 | $160,378 | $0 | $27,355 | $187,733 | 1 |
| Xinguo Jiang | Research Scientist II | 40 | $147,408 | $0 | $35,433 | $182,841 | 1 |
| Calvert Lee | Clinical Research Manager | 40 | $141,182 | $0 | $36,606 | $177,788 | 1 |
| Jenny Nhu-Thuy Dao | Accounting Manager | 40 | $137,110 | $0 | $32,903 | $170,013 | 1 |
| Stephanie L Hensey | Data Base Analyst II | 40 | $137,955 | $0 | $29,006 | $166,961 | 1 |
| Junliang Pan | Research Scientist II | 40 | $132,935 | $0 | $12,391 | $145,326 | 1 |
| Odette Harris | Director, Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Paul Heidenreich | Director, Secretary/Treasurer | 0 | $0 | $0 | $0 | $0 | 1 |
| Maheen Adamson | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Ngan Huang | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Ware Kuschner | Director from 12/27/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Jean Gurga | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Andrew R Hoffman | Director to 12/26/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Lisa Howard | Statutory VA Director to 3/31/23 | 0 | $0 | $0 | $0 | $0 | 1 |
| Meghan Kemnec | Statutory Non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Mike Kozal | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Jennifer Lee | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Lawrence Leung | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Payam Massaband | Statutory VA Director from 7/15/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Ferid Murad | Director to 1/24/23 | 0 | $0 | $0 | $0 | $0 | 1 |
| Mark Nicolls | Director to 6/10/23 | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert Sloss | Statutory Non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Philip Tsao | Director | 0 | $0 | $0 | $0 | $0 | 1 |
2021 · 24 people listed · 10 paid, $1.7M · 248 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Michael Anthony Hindery | CEO thru 9/1/21 | 0 | $219,081 | $0 | $29,844 | $248,925 | 1 |
| Elaine Staats | CEO from 12/1/21 | 40 | $170,065 | $0 | $38,883 | $208,948 | 1 |
| Lisa Clark | HR Director | 40 | $173,401 | $0 | $16,596 | $189,997 | 1 |
| Lily Ibragimov | Director of Finance & Accounting | 40 | $161,936 | $0 | $25,101 | $187,037 | 1 |
| Xinguo Jiang | Principal Investigator | 40 | $141,846 | $0 | $31,039 | $172,885 | 1 |
| Mary L Thornton | Director of Operations | 40 | $145,661 | $0 | $24,132 | $169,793 | 1 |
| Wen Amy Tian | Research Scientist | 40 | $151,200 | $0 | $11,520 | $162,720 | 1 |
| Maheen Adamson | Principal Investigator | 40 | $148,770 | $0 | $13,074 | $161,844 | 1 |
| Jennifer J Crockett | Assoc Dir of Research Administration | 40 | $139,692 | $0 | $13,880 | $153,572 | 1 |
| Ferid Murad | Director | 0 | $42,012 | $0 | $3,781 | $45,793 | 1 |
| David J Clark | Director until 8/31/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Odette Harris | Director, Board Chair from 9/1/22 | 1 | $0 | $0 | $0 | $0 | 1 |
| Paul Heidenreich | Director, Secretary/Treasurer | 0 | $0 | $0 | $0 | $0 | 1 |
| Andrew R Hoffman | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Lisa Howard | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Meghan Kemnec | Statutory Non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Mike Kozal | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Jennifer Lee | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Lawrence Leung | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Payam Massaband | Statutory VA Director from 7/15/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Mark Nicolls | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| John Pollard | Statutory VA Director until 7/14/22 | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert Sloss | Statutory Non-VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Philip Tsao | Director | 0 | $0 | $0 | $0 | $0 | 1 |
2020 · 26 people listed · 10 paid, $1.7M · 273 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MICHAEL ANTHONY HINDERY | CEO UNTIL 9/1/21 | 40 | $286,211 | $0 | $37,458 | $323,669 | 1 |
| ELAINE STAATS | DIRECTOR OF SPONSORED RESEARCH | 40 | $154,949 | $0 | $35,730 | $190,679 | 1 |
| LISA CLARK | HR DIRECTOR | 40 | $171,978 | $0 | $16,561 | $188,539 | 1 |
| LILY IBRAGIMOV | DIRECTOR OF FINANCE & ACCOUNTING | 40 | $160,590 | $0 | $25,599 | $186,189 | 1 |
| XINGUO JIANG | RESEARCH SCIENTIST II | 40 | $139,412 | $0 | $31,039 | $170,451 | 1 |
| MARY L THORNTON | DIRECTOR OF DATA INTEGRITY | 40 | $144,762 | $0 | $24,132 | $168,894 | 1 |
| WEN AMY TIAN | RESEARCH SCIENTIST II | 40 | $147,369 | $0 | $11,520 | $158,889 | 1 |
| MAHEEN ADAMSON | PRINCIPAL INVESTIGATOR II | 40 | $142,984 | $0 | $13,074 | $156,058 | 1 |
| CUIPING PAN | BUSINESS DEVELOPMENT MANAGER III | 40 | $137,430 | $0 | $13,880 | $151,310 | 1 |
| FERID MURAD | DIRECTOR | 0 | $47,492 | $0 | $4,274 | $51,766 | 1 |
| LISA HOWARD | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MEGHAN KEMNEC ND | STATUTORY NON-VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MIKE KOZAL MD | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PAUL HEIDENREICH | DIRECTOR, SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | DIRECTOR/AUDIT COMMITTEE CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J CLARK | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS MD MPH | DIRECTOR UNTIL 8/31/21 | 0 | $0 | $0 | $0 | $0 | 1 |
| ANDREW R HOFFMAN MD | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK NICOLLS | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SLOSS | STATUTORY NON-VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER LEE | STATUTORY VA DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS J FITZGERALD III | STATUTORY VA DIRECTOR UNTIL 1/31/21 | 0 | $0 | $0 | $0 | $0 | 1 |
| RINA N SHAH | STATUTORY VA DIRECTOR UNTIL 2/28/21 | 0 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ | STATUTORY NON-VA DIR. UNTIL 01/13/21 | 0 | $0 | $0 | $0 | $0 | 1 |
2019 · 21 people listed · 8 paid, $1.4M · 280 employees · 13 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MICHAEL ANTHONY HINDERY | CEO | 40 | $272,355 | $0 | $35,858 | $308,213 | 1 |
| ELAINE STAATS | DIRECTOR OF SPONSORED RESEARCH | 40 | $142,041 | $0 | $36,321 | $178,362 | 1 |
| LISA CLARK | HR DIRECTOR | 40 | $166,697 | $0 | $4,832 | $171,529 | 1 |
| LILY IBRAGIMOV | DIRECTOR OF FINANCE & ACCOUNTING | 40 | $146,280 | $0 | $24,012 | $170,292 | 1 |
| MARY L THORNTON | DIRECTOR OF DATA INTEGRITY | 40 | $140,330 | $0 | $23,779 | $164,109 | 1 |
| BONNIE OIKING LIANG | CFO/COO UNTIL 06/30/19 | 40 | $137,572 | $0 | $22,531 | $160,103 | 1 |
| WEN AMY TIAN | RESEARCH SCIENTIST II | 40 | $140,624 | $0 | $13,162 | $153,786 | 1 |
| FERID MURAD | DIRECTOR | 0 | $46,432 | $0 | $4,165 | $50,597 | 1 |
| MARK NICOLLS | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J CLARK | DIRECTOR, SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ | STATUTORY NON-VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS J FITZGERALD III | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MARY K GOLDSTEIN | DIRECTOR UNTIL 05/22/20 | 0 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | DIRECTOR/AUDIT COMMITTEE MEMBER | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SLOSS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | DIRECTOR/AUDIT COMMITTEE MEMBER | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER LEE | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| RINA N SHAH | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PAUL HEIDENREICH | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2018 · 19 people listed · 8 paid, $1.3M · 299 employees · 11 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| BONNIE OIKING LIANG | CFO/COO | 40 | $207,567 | $0 | $40,290 | $247,857 | 1 |
| MICHAEL ANTHONY HINDERY | CEO | 40 | $216,452 | $0 | $11,131 | $227,583 | 1 |
| ELAINE STAATS | DIRECTOR OF SPONSORED RESEARCH | 40 | $135,660 | $0 | $33,219 | $168,879 | 1 |
| MARY L THORNTON | DIRECTOR OF DATA INTEGRITY | 40 | $137,063 | $0 | $22,513 | $159,576 | 1 |
| LILY IBRAGIMOV | DIRECTOR OF FINANCE AND ACCOUNTING | 40 | $135,241 | $0 | $22,095 | $157,336 | 1 |
| MAHEEN ADAMSON | RESEARCH SCIENTIST II | 40 | $125,307 | $0 | $30,347 | $155,654 | 1 |
| WEN AMY TIAN | RESEARCH SCIENTIST II | 40 | $130,507 | $0 | $19,930 | $150,437 | 1 |
| FERID MURAD | DIRECTOR | 10 | $47,500 | $0 | $3,919 | $51,419 | 1 |
| MARK NICOLLS | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | STATUTORY VA DIRECTOR, SECR/TREAS | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J CLARK | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS J FITZGERALD III | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MARY K GOLDSTEIN | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | STATUTORY VA DIR/AUD COMM MEMB | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SLOSS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | STATUTORY VA DIR/AUDIT COMMITTE CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| JENNIFER LEE | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2017 · 19 people listed · 8 paid, $1.3M · 309 employees · 10 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| KERSTIN LYNAM | CEO THRU 11/14/17 | 40 | $264,229 | $0 | $37,689 | $301,918 | 1 |
| BONNIE OIKING LIANG | CFO/COO & INT CEO 11/15/17-1/31/18 | 40 | $226,226 | $0 | $29,482 | $255,708 | 1 |
| ELAINE STAATS | DIRECTOR OF SPONSORED RESEARCH | 40 | $131,249 | $0 | $30,425 | $161,674 | 1 |
| MARY L THORNTON | DIRECTOR OF DATA INTEGRITY | 40 | $133,586 | $0 | $21,269 | $154,855 | 1 |
| LILY IBRAGIMOV | DIRECTOR OF ACCOUNTING | 40 | $127,319 | $0 | $20,338 | $147,657 | 1 |
| WEN AMY TIAN | RESEARCH SCIENTIST II | 40 | $123,360 | $0 | $19,369 | $142,729 | 1 |
| JUNLIANG PAN | RESEARCH SCIENTIST II | 40 | $117,304 | $0 | $19,218 | $136,522 | 1 |
| FERID MURAD | DIRECTOR | 10 | $37,865 | $0 | $0 | $37,865 | 1 |
| MARK NICOLLS | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | STATUTORY VA DIRECTOR, SECR/TREAS | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID J CLARK | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS J FITZGERALD III | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MARY K GOLDSTEIN | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | STATUTORY VA DIR/AUD COMM. MEMB | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERT SLOSS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | STATUTORY VA DIR/AUD COMM. CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL ANTHONY HINDERY | CEO START 2/1/18 | 40 | $0 | $0 | $0 | $0 | 1 |
2016 · 19 people listed · 7 paid, $1.3M · 313 employees · 12 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Kerstin Lynam | CEO | 40 | $275,453 | $0 | $35,991 | $311,444 | 1 |
| Bonnie Oiking Liang | CFO/COO | 40 | $207,956 | $0 | $15,578 | $223,534 | 1 |
| Mary L Thornton | Director of Data Integrity | 40 | $131,963 | $0 | $20,218 | $152,181 | 1 |
| Lily Ibragimov | Controller | 40 | $123,522 | $0 | $19,279 | $142,801 | 1 |
| Wen Amy Tian | Research Scientist II | 40 | $123,860 | $0 | $18,723 | $142,583 | 1 |
| Stephanie L Hensey | Database Analyst II | 40 | $119,657 | $0 | $22,311 | $141,968 | 1 |
| Xinguo Jiang | Research Scientist II | 40 | $117,400 | $0 | $23,707 | $141,107 | 1 |
| Thomas J Fitzgerald III | Statutory VA Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Charlie Conz | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Mary K Goldstein | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Lawrence Leung | Statutory VA Director, Secr./Treas. | 1 | $0 | $0 | $0 | $0 | 1 |
| David J Clark | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Odette Harris | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Philip Tsao | Statutory VA Dir/Aud Committee Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Mark Nicolls | Director, Board Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Ferid Murad | Director | 10 | $0 | $0 | $0 | $0 | 1 |
| John Pollard | Statutory VA Dir/Aud Committee Memb | 0 | $0 | $0 | $0 | $0 | 1 |
| Robert Sloss | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| Phillip L Jelsma | Director through 7/26/2017 | 0 | $0 | $0 | $0 | $0 | 1 |
2015 · 18 people listed · 7 paid, $1.1M · 338 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| KERSTIN LYNAM | CEO | 40 | $250,331 | $0 | $35,881 | $286,212 | 1 |
| MARY THORNTON | IT Director | 40 | $135,002 | $0 | $19,959 | $154,961 | 1 |
| STEPHANIE L HENSEY | DATABASE MANAGER I | 40 | $129,315 | $0 | $22,843 | $152,158 | 1 |
| MICHELLE HERNANDEZ | HR DIRECTOR (Thru 02/2016) | 40 | $120,603 | $0 | $21,022 | $141,625 | 1 |
| WEN AMY TIAN | RESEARCH SCIENTIST II | 40 | $117,899 | $0 | $17,994 | $135,893 | 1 |
| LILY IBRAGIMOV | CONTROLLER | 40 | $115,197 | $0 | $18,077 | $133,274 | 1 |
| BONNIE LIANG | CFO/COO | 40 | $66,518 | $0 | $2,764 | $69,282 | 1 |
| MARK NICOLLS | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG STATUTORY VA | DIRECTOR, SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO Statutory VA | DIRector, CHAIR OF AUDIT Committee | 1 | $0 | $0 | $0 | $0 | 1 |
| THOMAS J FITZGERALD III | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD STATUTORY VA | DIRECTOR, AUDIT Committee MEMBER | 0 | $0 | $0 | $0 | $0 | 1 |
| DAVID CLARK | VA DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS | VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILLIP L JELSMA | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH JOYCE FREEMAN | Statutory VA DIRECTOR (Thru 06/2016) | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | DIRECTOR (Thru 06/2016) | 0 | $0 | $0 | $0 | $0 | 1 |
2014 · 20 people listed · 7 paid, $1.2M · 331 employees · 4 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| KERSTIN LYNAM | CEO | 40 | $258,233 | $0 | $15,759 | $273,992 | 1 |
| MARY THORNTON THRU 53115 | COO | 40 | $157,245 | $0 | $21,645 | $178,890 | 1 |
| STEPHANY HENSEY | DATABASE ADMINISTRATOR | 40 | $139,442 | $0 | $20,177 | $159,619 | 1 |
| BRIAN DOHERTY | IT MANAGER | 40 | $134,588 | $0 | $17,062 | $151,650 | 1 |
| LILY IBRAGIMOV | CONTROLLER | 40 | $123,910 | $0 | $18,136 | $142,046 | 1 |
| MICHELLE HERNANDEZ | HR DIRECTOR | 40 | $119,272 | $0 | $17,697 | $136,969 | 1 |
| IRINA GORODETSKAYA | PROGRAM MANAGER I | 40 | $117,165 | $0 | $13,223 | $130,388 | 1 |
| ELIZABETH JOYCE FREEMAN | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILLIP L JELSMA | DIRECTOR, AUDIT COMMITTEE MEMBER | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD STATUTORY VA | DIRECTOR, AUDIT COMMITTEE MEMBER | 0 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG STATUTORY VA | DIRECTOR, SECRETARY/TREASURER | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID CLARK | DIRECTOR, BOARD CHAIR (THRU 7/1/15) | 1 | $0 | $0 | $0 | $0 | 1 |
| ODETTE HARRIS SINCE 92315 | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CHARLIE CONZ SINCE 11415 | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERTA OKA THRU 083115 | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| BARCLAY KAMB THRU 092615 | STATUTORY NON-FEDERAL DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | STATUTORY NON-FEDERAL DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | STATUTORY VA DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| MARK NICOLLS SINCE 7215 | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| BONNIE LIANG SINCE 7815 | CFO | 40 | $0 | $0 | $0 | $0 | 1 |
2013 · 19 people listed · 8 paid, $1.2M · 291 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DONNA MCCARTNEY | EXECUTIVE DIRECTOR | 40 | $164,275 | $0 | $16,186 | $180,461 | 1 |
| MARY THORNTON | COO | 40 | $140,574 | $0 | $31,232 | $171,806 | 1 |
| STEPHANIE HENSEY | DATABASE ADMINISTRATOR | 40 | $136,828 | $0 | $20,625 | $157,453 | 1 |
| BRIAN DOHERTY | IT MANAGER | 40 | $134,388 | $0 | $16,003 | $150,391 | 1 |
| LILY IBRAGIMOV | CONTROLLER | 40 | $114,648 | $0 | $17,869 | $132,517 | 1 |
| MAURINO ALBENETYH | PURCHASING MANAGER | 40 | $112,513 | $0 | $15,447 | $127,960 | 1 |
| BRIAN ZABEL | RESEARCH SCIENTIST | 40 | $109,619 | $0 | $16,252 | $125,871 | 1 |
| KERSTIN LYNAM | CEO | 40 | $106,806 | $0 | $7,460 | $114,266 | 1 |
| LAWRENCE LEUNG | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH JOYCE FREEMAN | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| MARK NICOLLS | DIRECTOR, SECRETARY/TREASURER | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS RANDO | DIRECTOR (THROUGH 6/11/14) | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| DAVID CLARK | DIRECTOR, BOARD CHAIR | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILLIP L JELSMA | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| BARCLAY KAMB | STATUTORY NON-FEDERAL DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| ROBERTA OKA | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | STATUTORY VA DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | STATUTORY NON-FEDERAL DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2011 · 16 people listed · 8 paid, $1.2M · 280 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DONNA L MCCARTNEY | EXECUTIVE DIRECTOR | 40 | $199,260 | $0 | $19,954 | $219,214 | 1 |
| MARY L THORNTON | COO | 40 | $134,562 | $0 | $19,682 | $154,244 | 1 |
| STEPHANIE HENSEY | DATABASE ADMINISTRATOR | 40 | $133,833 | $0 | $18,411 | $152,244 | 1 |
| PATRICIA GRICE | CFO | 40 | $131,703 | $0 | $17,136 | $148,839 | 1 |
| JOHN HABER | PRINCIPAL INVESTIGATOR | 40 | $114,374 | $0 | $17,122 | $131,496 | 1 |
| BRIAN DOHERTY | IT MANAGER | 40 | $112,979 | $0 | $14,841 | $127,820 | 1 |
| ELAINE STAATS | DIRECTOR OF SPONSORED RESEARCH | 40 | $108,384 | $0 | $14,986 | $123,370 | 1 |
| RUDOLF MOOS | PRINCIPAL INVESTIGATOR | 23 | $108,628 | $0 | $8,178 | $116,806 | 1 |
| ELIZABETH JOYCE FREEMAN | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS RANDO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS OWENS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| BARCLAY KAMB | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP TSAO | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2010 · 15 people listed · 8 paid, $1.1M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DONNA L MCCARTNEY | EXECUTIVE DIRECTOR | 40 | $189,814 | $0 | $17,840 | $207,654 | 1 |
| MARY L THORNTON | COO | 40 | $126,129 | $0 | $18,435 | $144,564 | 1 |
| STEPHANIE HENSEY | DATABASE ADMIN | 40 | $124,431 | $0 | $17,278 | $141,709 | 1 |
| PATRICIA GRICE | CFO | 40 | $122,541 | $0 | $17,136 | $139,677 | 1 |
| BRIAN DOHERTY | IT MANAGER | 40 | $118,929 | $0 | $17,814 | $136,743 | 1 |
| MARY MCELRATH | NURSE COORDINATOR | 40 | $104,432 | $0 | $15,028 | $119,460 | 1 |
| LILY IBRAGIMOV | CONTROLLER | 40 | $102,201 | $0 | $15,615 | $117,816 | 1 |
| CHRISTOS CONSTANTINOU | PRINCIPAL INVESTIGATOR | 30 | $103,014 | $0 | $10,275 | $113,289 | 1 |
| ELIZABETH JOYCE FREEMAN | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS RANDO | DIRECTOR | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS OWENS | DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| BARCLAY KAMB | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
2009 · 16 people listed · 8 paid, $1.1M · 0 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DONNA L MCCARTNEY | Executive Director | 40 | $180,818 | $0 | $18,098 | $198,916 | 1 |
| MARY L THORNTON | Chief Operating Officer | 40 | $121,310 | $0 | $17,710 | $139,020 | 1 |
| Brian J Doherty | IT Manager | 40 | $121,428 | $0 | $17,180 | $138,608 | 1 |
| Stephanie L hensey | Database Admin | 40 | $117,973 | $0 | $16,415 | $134,388 | 1 |
| PATRICIA GRICE | Chief Financial Officer | 40 | $117,329 | $0 | $16,370 | $133,699 | 1 |
| mary k McElrath | Nurse Coordinator | 40 | $112,086 | $0 | $16,035 | $128,121 | 1 |
| KEVIN MCGILL | BIOMEDICAL ENGINEER | 40 | $106,959 | $0 | $15,390 | $122,349 | 1 |
| VIRGINIA C WONG | former HR DIRECTOR | 40 | $105,120 | $0 | $15,198 | $120,318 | 1 |
| ELIZABETH JOYCE FREEMAN | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| THOMAS RANDO | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID CLARK | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| JOHN POLLARD | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| LAWRENCE LEUNG | VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| DOUGLAS OWENS | Director | 0 | $0 | $0 | $0 | $0 | 1 |
| BARCLAY KAMB | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
| CAROL OLSON | NON-VA STATUTORY DIRECTOR | 0 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2018 · 2 contractors · $215K
| Name | Location | Service | Paid |
|---|---|---|---|
| PUNCTUM DESIGN LLC | LOS GATOS, CA | WEB DESIGN | $112,440 |
| MOSS ADAMS LLP | PASADENA, CA | CPA SERVICES | $102,440 |
2017 · 1 contractor · $102K
| Name | Location | Service | Paid |
|---|---|---|---|
| TOUSSAINT BRADFORD P | SAN CARLOS, CA | LEAN CONSULTING SERVICES | $102,000 |
2016 · 2 contractors · $247K
| Name | Location | Service | Paid |
|---|---|---|---|
| Toussaint Bradford P | San Carlos, CA | Lean Consulting Services | $141,525 |
| Moss Adams LLP | Pasadena, CA | Auditing and Tax Services | $105,925 |
2013 · 1 contractor · $101K
| Name | Location | Service | Paid |
|---|---|---|---|
| KONO CONSULTING INC | SOFTWARE CONSULTING | $101,382 |
2011 · 5 contractors · $2.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| STANFORD UNIVERSITY | SAN FRANCISCO, CA | RESEARCH SERVICES | $994,791 |
| VA PA HEALTH CARE SYSTEM | PALO ALTO, CA | RESEARCH SERVICES | $739,577 |
| GENEFLUIDICS INC | MONTEREY PARK, CA | RESEARCH SERVICES | $425,362 |
| NYU SCHOOL OF MEDICINE | BOSTON, MA | RESEARCH SERVICES | $261,360 |
| UNIVERSITY OF ARIZONA | TUSCON, AZ | RESEARCH SERVICES | $223,030 |
2010 · 5 contractors · $2.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| STANFORD UNIVERSITY | SAN FRANCISCO, CA | RESEARCH SERVICES | $1,416,439 |
| VA PA HEALTH CARE SYSTEM | PALO ALTO, CA | RESEARCH SERVICES | $626,512 |
| GENEFLUIDICS INC | MONTEREY PARK, CA | RESEARCH SERVICES | $326,467 |
| SRI INTERNATIONAL | MENLO PARK, CA | RESEARCH SERVICES | $273,187 |
| UNIVERSITY OF ARIZONA | TUSCON, AZ | RESEARCH SERVICES | $245,078 |
2009 · 5 contractors · $2.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| Stanford University | San Francisco, CA | Research Services | $990,096 |
| va pa health care system | Palo Alto, CA | Research Services | $604,326 |
| GeneFluidics Inc | monterey park, CA | research services | $386,417 |
| UNIVERSITY OF ARIZONA | TUSCON, AZ | research services | $222,495 |
| University of California | Oakland, CA | research services | $176,878 |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2026 | $15,049,728 | $0 | 36 |
| 2025 | $15,438,038 | $0 | 26 |
| 2024 | $13,336,627 | -$225 | 43 |
| 2023 | $11,499,672 | $0 | 30 |
| 2022 | $11,701,772 | $0 | 45 |
| 2021 | $11,510,776 | $0 | 41 |
| 2020 | $14,631,267 | $0 | 41 |
| 2019 | $13,674,777 | $0 | 49 |
| 2018 | $21,913,143 | $0 | 49 |
| 2017 | $16,142,269 | $0 | 58 |
| 2016 | $15,071,712 | $0 | 34 |
| 2015 | $15,564,372 | $0 | 45 |
| 2014 | $18,506,427 | $0 | 48 |
| 2013 | $16,141,248 | $0 | 43 |
| 2012 | $14,268,294 | $0 | 33 |
| 2011 | $12,957,728 | $0 | 39 |
| 2010 | $12,415,826 | $0 | 38 |
| 2009 | $14,094,759 | $0 | 44 |
| 2008 | $7,501,218 | $0 | 21 |
| 2007 | $7,118,211 | $0 | 25 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | NEUROIMMUNE CONTRIBUTIONS TO LOW BACK PAIN - PROJECT SUMMARY/ABSTRACT: LOW BACK PAIN (LBP) IS EXTREMELY COMMON AND SUBSTANTIALLY DISABLING. THE POINT PREVALENCE | $3,304,634 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | PROTEIN HOMEOSTASIS AND PROTEOTOXICITY MECHANISMS - PROTEIN MISFOLDING IS A PATHOGNOMONIC FEATURE OF NEURODEGENERATIVE DISEASES. THE MECHANISMS BY WHICH PROTEIN | $1,819,891 |
| 2026 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | STUDY OF ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND CARDIOVASCULAR DISEASE IN VETERANS WITH BURN PIT EXPOSURES USING ADVANCED IMAGING AND 3D HEART TISSUE MODELS | $1,163,385 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEPRESCRIBING CARDIOVASCULAR MEDICATIONS AMONG PERSONS WITH AND WITHOUT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LONG-TERM CARE - PROJECT SUMMARY/ABSTRACT T | $774,239 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL LYMPHOCYTE CHEMOATTRACTANT RECEPTOR AND LIGAND - PROJECT SUMMARY/ABSTRACT THE IMMUNE SYSTEM AT MUCOSAL SITES HAS EVOLVED TO MEDIATE RAPID IMMUNITY TO INVA | $671,860 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $638,104 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERSECTING CLINICAL, GENOMIC, AND EXPERIMENTAL INVESTIGATION TO UNDERSTAND THE MECHANISMS AND IMPACT OF CORONARY ARTERY PATTERNING - PROJECT SUMMARY/ABSTRACT | $633,955 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DYSREGULATED METABOLIC-MATRIX AXIS IN MASH/HCC - PROJECT SUMMARY/ABSTRACT THE INCREASING PREVALENCE AND SEVERITY OF METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPAT | $633,393 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | ONLINE YOGA VS ACCEPTANCE AND COMMITMENT THERAPY FOR TREATING CHRONIC MUSCULOSKELETAL PAIN - PROJECT SUMMARY/ABSTRACT MORE THAN 50% OF VETERANS IN PRIMARY CARE | $631,179 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE IMPACT OF AGE ON KETOGENESIS AND THE LIVER-GUT AXIS - PROJECT SUMMARY/ABSTRACT THE PREVALENCE OF METABOLIC DISEASE AFFECTING THE LIVER AND GUT IS STEADILY I | $596,400 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUALLY SUPERVISED EXERCISE FOR KIDNEY TRANSPLANT CANDIDATES - KIDNEY TRANSPLANTATION (KT) IS THE BEST TREATMENT FOR KIDNEY FAILURE; HOWEVER, DUE TO THE SHORT | $590,344 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CHROMATIN SIGNALING MECHANISMS IN METABOLIC AGING AND DISEASE - ABSTRACT OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AN | $542,730 |
| 2026 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | ASSESSING THE IMPACT OF DTMS ON NEURAL TARGETS ASSOCIATED WITH ALCOHOL USE DISORDER - ABSTRACT BACKGROUND: CONVERGING LINES OF EVIDENCE SUGGEST THAT NEUROMODULA | $540,248 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF A BIOENGINEERED THERAPEUTIC DEVICE FOR THE PREVENTION OF LYMPHEDEMA - ABSTRACT: LYMPHEDEMA AFFECTS APPROXIMATELY 200 MILLION PATIENTS GLOBALLY, A | $530,645 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $515,615 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $384,256 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTIONAL AND MOLECULAR DISSECTION OF MUTANT CALRETICULIN IN MYELOPROLIFERATIVE NEOPLASMS | $355,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | E-CIGARETTES EPIGENETICALLY AUGMENT TRANSGENERATIONAL ABDOMINAL AORTIC ANEURYSM - PROJECT SUMMARY ABDOMINAL AORTIC ANEURYSM (AAA) DISEASE IS A COMMON, MORBID AN | $355,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CONCURRENT ANTI-AMYLOID THERAPY AND EXERCISE FOR THE TREATMENT OF ALZHEIMER'S DISEASE - PROJECT SUMMARY/ABSTRACT ALZHEIMER’S DISEASE (AD) AFFECTS NEARLY 7 MILLI | $301,575 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | LEVERAGING CONSANGUINITY IN PAKISTAN TO UNCOVER THE GENOMIC ARCHITECTURE OF ALZHEIMER'S DISEASE: FEASIBILITY STUDY WITH ENIGMA-PAK - PROJECT SUMMARY/ABSTRACT CU | $163,304 |
| 2026 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | RACIAL AND ETHNIC DISPARITIES IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG PATIENTS WITH CIRRHOSIS ACROSS FIVE SAFETY NET ORGANIZATIONS - BACKGROUND: IMPLEMEN | $152,854 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR THE MICROVASCULATURE IN AIRWAY TRANSPLANTATION | -$200 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS VS AUDIT AND FEEDBACK: A CLUSTER RANDOMIZED TRIAL OF MECHANISMS OF IMPLEMENTATION CHANGE TO EXPAND REACH OF EVIDENCE-BASED ADDICTI | -$713 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EFFICACY OF TWICE WEEKLY HEMODIALYSIS IN PATIENTS WITH RESIDUAL KIDNEY FUNCTION | -$3,736 |
| 2026 | Federal Emergency Management Agency | Grant or other assistance | ASSISTANCE TO FIREFIGHTERS GRANT 97.044 | ASSISTANCE TO FIREFIGHTERS GRANT | -$4,845 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | B LYMPHOCYTE-MEDIATED AUTOIMMUNITY IN PAIN AFTER TRAUMA | -$239,386 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | ACCELERATED TREATMENT FOR CO-OCCURRING INSOMNIA, NIGHTMARES, AND PTSD | $5,754,710 |
| 2025 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | ENGAGEMENT OF VETERANS WITH LUNG CANCER | $923,000 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEPRESCRIBING CARDIOVASCULAR MEDICATIONS AMONG PERSONS WITH AND WITHOUT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LONG-TERM CARE - PROJECT SUMMARY/ABSTRACT T | $773,668 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL LYMPHOCYTE CHEMOATTRACTANT RECEPTOR AND LIGAND - PROJECT SUMMARY/ABSTRACT THE IMMUNE SYSTEM AT MUCOSAL SITES HAS EVOLVED TO MEDIATE RAPID IMMUNITY TO INVA | $672,536 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERSECTING CLINICAL, GENOMIC, AND EXPERIMENTAL INVESTIGATION TO UNDERSTAND THE MECHANISMS AND IMPACT OF CORONARY ARTERY PATTERNING - PROJECT SUMMARY/ABSTRACT | $654,145 |
| 2025 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | ONLINE YOGA VS ACCEPTANCE AND COMMITMENT THERAPY FOR TREATING CHRONIC MUSCULOSKELETAL PAIN - PROJECT SUMMARY/ABSTRACT MORE THAN 50% OF VETERANS IN PRIMARY CARE | $639,882 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $638,103 |
| 2025 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | RACIAL AND ETHNIC DISPARITIES IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG PATIENTS WITH CIRRHOSIS ACROSS FIVE SAFETY NET ORGANIZATIONS - BACKGROUND: IMPLEMEN | $628,392 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUALLY SUPERVISED EXERCISE FOR KIDNEY TRANSPLANT CANDIDATES - KIDNEY TRANSPLANTATION (KT) IS THE BEST TREATMENT FOR KIDNEY FAILURE; HOWEVER, DUE TO THE SHORT | $599,289 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | APPLYING HYPERTENSION CLINICAL TRIALS TO REAL WORLD ADULTS WITH CKD - PROJECT SUMMARY / ABSTRACT HYPERTENSION AFFECTS MORE THAN 80% OF ADULTS WITH CHRONIC KIDNE | $596,163 |
| 2025 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | ASSESSING THE IMPACT OF DTMS ON NEURAL TARGETS ASSOCIATED WITH ALCOHOL USE DISORDER - ABSTRACT BACKGROUND: CONVERGING LINES OF EVIDENCE SUGGEST THAT NEUROMODULA | $551,464 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF A BIOENGINEERED THERAPEUTIC DEVICE FOR THE PREVENTION OF LYMPHEDEMA - ABSTRACT: LYMPHEDEMA AFFECTS APPROXIMATELY 200 MILLION PATIENTS GLOBALLY, A | $540,476 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $511,139 |
| 2025 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HISTONE DEACETYLATION SIGNALING IN AGING AND CANCER PATHWAYS - OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AND EPIGENETI | $452,432 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | THE COMBINATION OF ANTI-AMYLOID THERAPY AND RTMS FOR AD - PROJECT SUMMARY / ABSTRACT MANY INDIVIDUALS SUFFER FROM DEMENTIA-RELATED COGNITIVE IMPAIRMENT DUE TO M | $398,046 |
| 2025 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $394,396 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ALTERED ENS NEUROIMMUNE INTERACTIONS DISRUPT GASTROINTESTINAL MOTILITY IN ALZHEIMERS DISEASE - ABSTRACT GASTROINTESTINAL (GI) DISORDERS INCLUDING CONSTIPATION A | $355,280 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | E-CIGARETTES EPIGENETICALLY AUGMENT TRANSGENERATIONAL ABDOMINAL AORTIC ANEURYSM - PROJECT SUMMARY ABDOMINAL AORTIC ANEURYSM (AAA) DISEASE IS A COMMON, MORBID AN | $355,000 |
| 2025 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR LEUKOTRIENE B4 IN LYMPHEDEMA | -$82 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | INCREASING ACCESS TO EVIDENCED-BASED PTSD TREATMENT IN THE MILITARY: BEHAVIORAL HEALTH TECHNICIAN-DELIVERED WRITTEN EXPOSURE THERAPY | $2,398,281 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEPRESCRIBING CARDIOVASCULAR MEDICATIONS AMONG PERSONS WITH AND WITHOUT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN LONG-TERM CARE - PROJECT SUMMARY/ABSTRACT T | $727,756 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | NOVEL LYMPHOCYTE CHEMOATTRACTANT RECEPTOR AND LIGAND - PROJECT SUMMARY/ABSTRACT THE IMMUNE SYSTEM AT MUCOSAL SITES HAS EVOLVED TO MEDIATE RAPID IMMUNITY TO INVA | $719,405 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | $709,716 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERSECTING CLINICAL, GENOMIC, AND EXPERIMENTAL INVESTIGATION TO UNDERSTAND THE MECHANISMS AND IMPACT OF CORONARY ARTERY PATTERNING - PROJECT SUMMARY/ABSTRACT | $703,368 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $638,104 |
| 2024 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | RACIAL AND ETHNIC DISPARITIES IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG PATIENTS WITH CIRRHOSIS ACROSS FIVE SAFETY NET ORGANIZATIONS - BACKGROUND: IMPLEMEN | $633,897 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | APPLYING HYPERTENSION CLINICAL TRIALS TO REAL WORLD ADULTS WITH CKD - PROJECT SUMMARY / ABSTRACT HYPERTENSION AFFECTS MORE THAN 80% OF ADULTS WITH CHRONIC KIDNE | $589,877 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATORY T CELLS AND PULMONARY HYPERTENSION - PROJECT SUMMARY / ABSTRACT CLINICAL AND PRECLINICAL STUDIES INDICATE THAT AUTOIMMUNITY AND CHRONIC INFLAMMATION, | $570,589 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUALLY SUPERVISED EXERCISE FOR KIDNEY TRANSPLANT CANDIDATES - KIDNEY TRANSPLANTATION (KT) IS THE BEST TREATMENT FOR KIDNEY FAILURE; HOWEVER, DUE TO THE SHORT | $560,883 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF A BIOENGINEERED THERAPEUTIC DEVICE FOR THE PREVENTION OF LYMPHEDEMA - ABSTRACT: LYMPHEDEMA AFFECTS APPROXIMATELY 200 MILLION PATIENTS GLOBALLY, A | $556,684 |
| 2024 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $529,696 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR HYPOXIA-INDUCIBLE FACTORS IN LYMPHEDEMA - PROJECT SUMMARY / ABSTRACT LYMPHEDEMA IS A CHRONIC AND DEBILITATING CONDITION CURRENTLY WITHOUT AP | $524,950 |
| 2024 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | B LYMPHOCYTE-MEDIATED AUTOIMMUNITY IN PAIN AFTER TRAUMA | $505,706 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HISTONE DEACETYLATION SIGNALING IN AGING AND CANCER PATHWAYS - OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AND EPIGENETI | $495,710 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $403,063 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ALTERED ENS NEUROIMMUNE INTERACTIONS DISRUPT GASTROINTESTINAL MOTILITY IN ALZHEIMERS DISEASE - ABSTRACT GASTROINTESTINAL (GI) DISORDERS INCLUDING CONSTIPATION A | $362,404 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTIONAL AND MOLECULAR DISSECTION OF MUTANT CALRETICULIN IN MYELOPROLIFERATIVE NEOPLASMS | $355,000 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROTEIN HOMEOSTASIS AND PROTEOTOXICITY MECHANISMS | $327,825 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | NOVEL FC RECEPTOR BLOCKERS AS DISEASE-MODIFYING ANALGESICS | $284,000 |
| 2024 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | APPLICATION OF ELECTRICAL CURRENT FOR PROMOTING LYMPHATIC REGENERATION | $260,500 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | LEVERAGING CONSANGUINITY IN PAKISTAN TO UNCOVER THE GENOMIC ARCHITECTURE OF ALZHEIMER'S DISEASE: FEASIBILITY STUDY WITH ENIGMA-PAK - PROJECT SUMMARY/ABSTRACT CU | $223,902 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DECIPHERING THE MOLECULAR MECHANISMS OF RESPONSE TO COVID VACCINE IN KIDNEY TRANSPLANT RECIPIENTS - PROJECT SUMMARY / ABSTRACT SOLID ORGAN TRANSPLANT RECIPIENTS | $197,333 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | TARGETING THE DEFAULT MODE NETWORK: A TMS-FMRI STUDY - PROJECT SUMMARY / ABSTRACT POST-TRAUMATIC STRESS DISORDER (PTSD) IS A DEVASTATING ILLNESS IN WHICH TRAUMA | $177,500 |
| 2024 | National Science Foundation | Grant or other assistance | ENGINEERING 47.041 | BRITE PIVOT: ENGINEERED EXTRACELLULAR MATRIX CUES AFFECTING ENDOTHELIAL PHENOTYPIC CHANGE -BLOOD VESSEL CELLS KNOWN AS ENDOTHELIAL CELLS CAN CHANGE TO ANOTHER T | $8,000 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LEVERAGING ROUTINE CLINICAL MATERIALS AND MOBILE TECHNOLOGY TO ASSESS CBT QUALITY | -$3 |
| 2024 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IN-HOME SLEEP MONITORING TO DETECT SUICIDE RISK IN VETERANS | -$107 |
| 2024 | Department of the Army | Contract | RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES 541720 | IGF::OT::IGF IMPLEMENTATION SCIENCE -PTSD | -$225 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | TARGETING CEREBROVASCULAR TGF SIGNALING IN ALZHEIMER'S DISEASE | -$260 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MOLECULAR MECHANISMS OF MAMMALIAN SIRT6 FUNCTION | -$499 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | COMPLEMENT COMPONENTS AS MEDIATORS OF CELL AND TISSUE AGING | -$863 |
| 2024 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | FEASIBILITY OF AT HOME TELEHEALTH YOGA FOR TREATING CHRONIC PAIN | -$1,012 |
| 2024 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR AND IMMUNE PROGRAMMING OF TUMOR-ASSOCIATED ENDOTHELIUM | -$1,497 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NONINVASIVE CORTICAL STIMULATION TO IMPROVE MEMORY IN MILD COGNITIVE IMPAIRMENT | -$8,839 |
| 2024 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | DEVELOPMENT OF A RISK FACTOR SCREEN FOR MENTAL HEALTH PROBLEMS AFTER SUDDEN ILLNESS OR INJURY | -$42,680 |
| 2024 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF ROTAVIRUS REPLICATION, VIRULENCE, AND HOST RANGE RESTRICTION BY THE INNATE IMMUNE SYSTEM | -$71,758 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | TARGETING INFLAMMATORY ASTROCYTE REACTIVITY IN MILD TRAUMATIC BRAIN INJURY | $1,400,500 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | $715,118 |
| 2023 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | RACIAL AND ETHNIC DISPARITIES IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG PATIENTS WITH CIRRHOSIS ACROSS FIVE SAFETY NET ORGANIZATIONS - BACKGROUND: IMPLEMEN | $639,127 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $638,104 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | APPLYING HYPERTENSION CLINICAL TRIALS TO REAL WORLD ADULTS WITH CKD - PROJECT SUMMARY / ABSTRACT HYPERTENSION AFFECTS MORE THAN 80% OF ADULTS WITH CHRONIC KIDNE | $631,829 |
| 2023 | National Science Foundation | Grant or other assistance | ENGINEERING 47.041 | BRITE PIVOT: ENGINEERED EXTRACELLULAR MATRIX CUES AFFECTING ENDOTHELIAL PHENOTYPIC CHANGE -BLOOD VESSEL CELLS KNOWN AS ENDOTHELIAL CELLS CAN CHANGE TO ANOTHER T | $608,000 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATORY T CELLS AND PULMONARY HYPERTENSION - PROJECT SUMMARY / ABSTRACT CLINICAL AND PRECLINICAL STUDIES INDICATE THAT AUTOIMMUNITY AND CHRONIC INFLAMMATION, | $602,055 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUALLY SUPERVISED EXERCISE FOR KIDNEY TRANSPLANT CANDIDATES - KIDNEY TRANSPLANTATION (KT) IS THE BEST TREATMENT FOR KIDNEY FAILURE; HOWEVER, DUE TO THE SHORT | $584,643 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS VS AUDIT AND FEEDBACK: A CLUSTER RANDOMIZED TRIAL OF MECHANISMS OF IMPLEMENTATION CHANGE TO EXPAND REACH OF EVIDENCE-BASED ADDICTI | $579,387 |
| 2023 | Defense Health Agency | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | ACCELERATED TREATMENT FOR CO-OCCURRING INSOMNIA, NIGHTMARES, AND PTSD | $560,089 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $542,135 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $541,040 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGING AND STEM CELL RESILIENCE - STEM CELLS ARE RESPONSIBLE FOR HOMEOSTASIS AND REPAIR OF MANY TISSUES IN THE BODY, AND STEM CELL EXHAUSTION IS ONE OF THE HALLM | $540,557 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR HYPOXIA-INDUCIBLE FACTORS IN LYMPHEDEMA - PROJECT SUMMARY / ABSTRACT LYMPHEDEMA IS A CHRONIC AND DEBILITATING CONDITION CURRENTLY WITHOUT AP | $535,664 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HISTONE DEACETYLATION SIGNALING IN AGING AND CANCER PATHWAYS - OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AND EPIGENETI | $509,282 |
| 2023 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR AND IMMUNE PROGRAMMING OF TUMOR-ASSOCIATED ENDOTHELIUM | $437,865 |
| 2023 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | UNDERSTANDING THE MECHANISTIC INTERRELATIONSHIP BETWEEN SLEEP, CO-OCCURRING CANNABIS AND ALCOHOL USE DISORDER, AND NEUROCIRCUIT DYSFUNCTION DURING EARLY ABSTINE | $379,827 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | ALTERED ENS NEUROIMMUNE INTERACTIONS DISRUPT GASTROINTESTINAL MOTILITY IN ALZHEIMERS DISEASE - ABSTRACT GASTROINTESTINAL (GI) DISORDERS INCLUDING CONSTIPATION A | $362,356 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | PROTEIN HOMEOSTASIS AND PROTEOTOXICITY MECHANISMS | $327,825 |
| 2023 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | DECIPHERING THE MOLECULAR MECHANISMS OF RESPONSE TO COVID VACCINE IN KIDNEY TRANSPLANT RECIPIENTS - PROJECT SUMMARY / ABSTRACT SOLID ORGAN TRANSPLANT RECIPIENTS | $255,459 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | TARGETING THE DEFAULT MODE NETWORK: A TMS-FMRI STUDY - PROJECT SUMMARY / ABSTRACT POST-TRAUMATIC STRESS DISORDER (PTSD) IS A DEVASTATING ILLNESS IN WHICH TRAUMA | $203,558 |
| 2023 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A NEW FRAMEWORK FOR UNDERSTANDING THE MECHANISMS OF DIASTOLIC DYSFUNCTION | -$28 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PHAGOCYTOSIS AND NOX2 IN LIVER FIBROGENESIS | -$5,764 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | TGF SIGNALING AS A NOVEL THERAPEUTIC TARGET FOR MILD TRAUMATIC BRAIN INJURY | -$19,572 |
| 2023 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IMPROVING AND SUSTAINING DELIVERY OF CPT FOR PTSD IN MENTAL HEALTH SYSTEMS | -$31,975 |
| 2023 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR REGULATION OF STEM CELL QUIESCENCE | -$37,408 |
| 2022 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | PHOTOACTIVATED REGENERATIVE COLLAGEN SEALANT FOR RAPID VISION RESTORATION AFTER DEEP CORNEAL INJURIES | $1,065,000 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | $720,515 |
| 2022 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | RACIAL AND ETHNIC DISPARITIES IN HEPATOCELLULAR CARCINOMA SURVEILLANCE AMONG PATIENTS WITH CIRRHOSIS ACROSS FIVE SAFETY NET ORGANIZATIONS - BACKGROUND: IMPLEMEN | $712,026 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | APPLYING HYPERTENSION CLINICAL TRIALS TO REAL WORLD ADULTS WITH CKD - PROJECT SUMMARY / ABSTRACT HYPERTENSION AFFECTS MORE THAN 80% OF ADULTS WITH CHRONIC KIDNE | $649,363 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | VIRTUALLY SUPERVISED EXERCISE FOR KIDNEY TRANSPLANT CANDIDATES - KIDNEY TRANSPLANTATION (KT) IS THE BEST TREATMENT FOR KIDNEY FAILURE; HOWEVER, DUE TO THE SHORT | $641,319 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATORY T CELLS AND PULMONARY HYPERTENSION - PROJECT SUMMARY / ABSTRACT CLINICAL AND PRECLINICAL STUDIES INDICATE THAT AUTOIMMUNITY AND CHRONIC INFLAMMATION, | $627,446 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR HYPOXIA-INDUCIBLE FACTORS IN LYMPHEDEMA - PROJECT SUMMARY / ABSTRACT LYMPHEDEMA IS A CHRONIC AND DEBILITATING CONDITION CURRENTLY WITHOUT AP | $612,344 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS VS AUDIT AND FEEDBACK: A CLUSTER RANDOMIZED TRIAL OF MECHANISMS OF IMPLEMENTATION CHANGE TO EXPAND REACH OF EVIDENCE-BASED ADDICTI | $569,949 |
| 2022 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR REGULATION OF STEM CELL QUIESCENCE | $569,605 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGING AND STEM CELL RESILIENCE - STEM CELLS ARE RESPONSIBLE FOR HOMEOSTASIS AND REPAIR OF MANY TISSUES IN THE BODY, AND STEM CELL EXHAUSTION IS ONE OF THE HALLM | $540,557 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MICRORNA REGULATION OF T CELL SENESCENCE | $537,169 |
| 2022 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $528,207 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR LEUKOTRIENE B4 IN LYMPHEDEMA | $497,241 |
| 2022 | National Science Foundation | Grant or other assistance | COMPUTER AND INFORMATION SCIENCE AND ENGINEERING 47.070 | COLLABORATIVE RESEARCH: SCH: QUANTIFYING CARDIAC PERFORMANCE BY MEASURING MYOFIBER STRAIN WITH ROUTINE MRI -THE GOAL OF THIS RESEARCH IS TO DEVELOP A NEW METHOD | $453,666 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HISTONE DEACETYLATION SIGNALING IN AGING AND CANCER PATHWAYS - OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AND EPIGENETI | $445,595 |
| 2022 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR AND IMMUNE PROGRAMMING OF TUMOR-ASSOCIATED ENDOTHELIUM | $435,453 |
| 2022 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $426,000 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR THE MICROVASCULATURE IN AIRWAY TRANSPLANTATION | $408,029 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | UNDERSTANDING THE MECHANISTIC INTERRELATIONSHIP BETWEEN SLEEP, CO-OCCURRING CANNABIS AND ALCOHOL USE DISORDER, AND NEUROCIRCUIT DYSFUNCTION DURING EARLY ABSTINE | $388,609 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROTEIN HOMEOSTASIS AND PROTEOTOXICITY MECHANISMS | $327,825 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EFFICACY OF TWICE WEEKLY HEMODIALYSIS IN PATIENTS WITH RESIDUAL KIDNEY FUNCTION | $315,980 |
| 2022 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CRCNS US-FRANCE RESEARCH PROPOSAL: PROBING THE DORSOLATERAL PREFRONTAL CORTEX AND CENTRAL EXECUTIVE NETWORK FOR IMPROVING NEUROMODULATION IN DEPRESSION - THE OV | $208,088 |
| 2022 | National Science Foundation | Grant or other assistance | ENGINEERING 47.041 | ISS: TISSUE ENGINEERED MUSCLE IN MICROGRAVITY AS A NOVEL PLATFORM TO STUDY SARCOPENIA | $59,999 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NOTCH SIGNALING AND SATELLITE CELL ACTIVATION | $4,250 |
| 2022 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | A NEW MUSCLE-BRAIN AXIS UNDERLYING THE COGNITIVE BENEFITS OF PHYSICAL ACTIVITY | $56 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | A BIOORTHOGONAL APPROACH TO STUDY MAMMALIAN AGING | $0 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ANTIBIOTICS AND HUMAN MICROBIAL COMMUNITY DYNAMICS | $0 |
| 2022 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MICRORNA REGULATION OF NICOTINE ACCELERATED AAAS | -$38 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | IMPROVING ACCESS TO PHARMACOTHERAPY FOR OPIOID USE DISORDER AMONG JUSTICE INVOLVED VETERANS | -$641 |
| 2022 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | HYPOSALIVATION AND THE HUMAN ORAL MICROBIOME | -$1,322 |
| 2022 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | INTENSIVE REFERRAL TO AL-ANON: BENEFITS TO CONCERNED OTHERS AND THEIR DRINKERS | -$5,091 |
| 2022 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS FOR EVIDENCE-BASED ADDICTION AND MENTAL HEALTHCARE | -$8,530 |
| 2022 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | CAN A CANINE COMPANION MODIFY CARDIAC AUTONOMIC REACTIVITY AND TONE IN PTSD? | -$26,896 |
| 2021 | Federal Emergency Management Agency | Grant or other assistance | ASSISTANCE TO FIREFIGHTERS GRANT 97.044 | ASSISTANCE TO FIREFIGHTERS GRANT | $1,500,000 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | $936,551 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | APPLYING HYPERTENSION CLINICAL TRIALS TO REAL WORLD ADULTS WITH CKD - PROJECT SUMMARY / ABSTRACT HYPERTENSION AFFECTS MORE THAN 80% OF ADULTS WITH CHRONIC KIDNE | $683,886 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | REGULATORY T CELLS AND PULMONARY HYPERTENSION - PROJECT SUMMARY / ABSTRACT CLINICAL AND PRECLINICAL STUDIES INDICATE THAT AUTOIMMUNITY AND CHRONIC INFLAMMATION, | $655,254 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR HYPOXIA-INDUCIBLE FACTORS IN LYMPHEDEMA - PROJECT SUMMARY / ABSTRACT LYMPHEDEMA IS A CHRONIC AND DEBILITATING CONDITION CURRENTLY WITHOUT AP | $612,344 |
| 2021 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS VS AUDIT AND FEEDBACK: A CLUSTER RANDOMIZED TRIAL OF MECHANISMS OF IMPLEMENTATION CHANGE TO EXPAND REACH OF EVIDENCE-BASED ADDICTI | $572,087 |
| 2021 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR REGULATION OF STEM CELL QUIESCENCE | $560,112 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR LEUKOTRIENE B4 IN LYMPHEDEMA | $559,566 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | AGING AND STEM CELL RESILIENCE - STEM CELLS ARE RESPONSIBLE FOR HOMEOSTASIS AND REPAIR OF MANY TISSUES IN THE BODY, AND STEM CELL EXHAUSTION IS ONE OF THE HALLM | $551,085 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $509,659 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF ROTAVIRUS REPLICATION, VIRULENCE, AND HOST RANGE RESTRICTION BY THE INNATE IMMUNE SYSTEM | $471,572 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | HISTONE DEACETYLATION SIGNALING IN AGING AND CANCER PATHWAYS - OUR BROAD RESEARCH GOAL IS TO UNDERSTAND CHROMATIN REGULATORY MECHANISMS IN NUCLEAR AND EPIGENETI | $471,174 |
| 2021 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR THE MICROVASCULATURE IN AIRWAY TRANSPLANTATION | $445,841 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MEMORY T CELL DEVELOPMENT AND SURVIVAL IN T CELL RESPONSES OF OLDER INDIVIDUALS | $445,613 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | COMPLEMENT COMPONENTS AS MEDIATORS OF CELL AND TISSUE AGING | $443,558 |
| 2021 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR AND IMMUNE PROGRAMMING OF TUMOR-ASSOCIATED ENDOTHELIUM | $441,760 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | EPIGENETIC REPROGRAMMING OF CELLULAR AGE - PROJECT SUMMARY CURRENT IDEAS THAT SYSTEMIC FACTORS REGULATE THE AGING OF CELLS AND TISSUES, IN TERMS OF BOTH PROMOT | $426,000 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | PROTEIN HOMEOSTASIS AND PROTEOTOXICITY MECHANISMS | $381,585 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INFLUENCE OF AGE ON CD4 T MEMORY CELLS | $365,417 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EFFICACY OF TWICE WEEKLY HEMODIALYSIS IN PATIENTS WITH RESIDUAL KIDNEY FUNCTION | $315,833 |
| 2021 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CRCNS US-FRANCE RESEARCH PROPOSAL: PROBING THE DORSOLATERAL PREFRONTAL CORTEX AND CENTRAL EXECUTIVE NETWORK FOR IMPROVING NEUROMODULATION IN DEPRESSION - THE OV | $201,859 |
| 2021 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | FEASIBILITY OF AT HOME TELEHEALTH YOGA FOR TREATING CHRONIC PAIN | $106,707 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NONINVASIVE CORTICAL STIMULATION TO IMPROVE MEMORY IN MILD COGNITIVE IMPAIRMENT | $59,537 |
| 2021 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | TARGETING CD22 TO RESTORE BRAIN HOMEOSTASIS IN ALZHEIMER'S DISEASE | $8,693 |
| 2021 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | THE ROLE OF OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION IN COGNITIVE IMPAIRMENTS IN GULF WAR ILLNESS | -$23 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | -$190 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PREDICTING RESILIENCE IN THE HUMAN MICROBIOME | -$275 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEFINING THE CONTRIBUTION OF ENAC TO ADH-MEDIATED WATER AND SODIUM EXCRETION | -$304 |
| 2021 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | THE BENEFIT AND BURDEN OF ELECTRONIC REMINDERS FOR OPTIMIZING PATIENT CARE | -$827 |
| 2021 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | EFFECTS OF INHALED NICOTINE ON VASCULAR MIR-24 ACTIVITY AND AAA FORMATION | -$1,325 |
| 2021 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS FOR EVIDENCE-BASED ADDICTION AND MENTAL HEALTHCARE | -$1,499 |
| 2021 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | -$210,471 |
| 2020 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | B LYMPHOCYTE-MEDIATED AUTOIMMUNITY IN PAIN AFTER TRAUMA | $2,454,998 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INFLUENCE OF AGE ON CD4 T MEMORY CELLS | $741,382 |
| 2020 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | FEASIBILITY OF AT HOME TELEHEALTH YOGA FOR TREATING CHRONIC PAIN | $636,537 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | LEVERAGING ROUTINE CLINICAL MATERIALS AND MOBILE TECHNOLOGY TO ASSESS CBT QUALITY | $634,252 |
| 2020 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | DEVELOPMENT OF A RISK FACTOR SCREEN FOR MENTAL HEALTH PROBLEMS AFTER SUDDEN ILLNESS OR INJURY | $610,092 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ANTIMICROBIAL RESISTANCE AND HORIZONTAL GENE TRANSFER IN THE HUMAN GUT MICROBIOME IN RESPONSE TO AN ANTIBIOTIC | $609,504 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IMPROVING AND SUSTAINING DELIVERY OF CPT FOR PTSD IN MENTAL HEALTH SYSTEMS | $592,261 |
| 2020 | National Institutes of Health | Grant or other assistance | DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS 93.279 | PARTICIPATORY SYSTEM DYNAMICS VS AUDIT AND FEEDBACK: A CLUSTER RANDOMIZED TRIAL OF MECHANISMS OF IMPLEMENTATION CHANGE TO EXPAND REACH OF EVIDENCE-BASED ADDICTI | $566,059 |
| 2020 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A CRITICAL ROLE FOR LEUKOTRIENE B4 IN LYMPHEDEMA | $560,491 |
| 2020 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | MOLECULAR REGULATION OF STEM CELL QUIESCENCE | $532,784 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PROGENITOR CELLS FOR HIGH ENDOTHELIUM IN THE IMMUNE RESPONSE | $509,659 |
| 2020 | National Institutes of Health | Grant or other assistance | LUNG DISEASES RESEARCH 93.838 | A CRITICAL ROLE FOR THE MICROVASCULATURE IN AIRWAY TRANSPLANTATION | $483,194 |
| 2020 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | A NEW FRAMEWORK FOR UNDERSTANDING THE MECHANISMS OF DIASTOLIC DYSFUNCTION | $476,279 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | REGULATION OF ROTAVIRUS REPLICATION, VIRULENCE, AND HOST RANGE RESTRICTION BY THE INNATE IMMUNE SYSTEM | $471,572 |
| 2020 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | IMMUNOLOGICAL CONTRIBUTIONS TO THE CHRONIFICATION OF PAIN. NEW AWARD. | $455,799 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | COMPLEMENT COMPONENTS AS MEDIATORS OF CELL AND TISSUE AGING | $443,558 |
| 2020 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TUMOR AND IMMUNE PROGRAMMING OF TUMOR-ASSOCIATED ENDOTHELIUM | $439,634 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MICRORNA REGULATION OF T CELL SENESCENCE | $429,251 |
| 2020 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | IN-HOME SLEEP MONITORING TO DETECT SUICIDE RISK IN VETERANS | $414,734 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MOLECULAR MECHANISMS OF MAMMALIAN SIRT6 FUNCTION | $374,022 |
| 2020 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | NONINVASIVE CORTICAL STIMULATION TO IMPROVE MEMORY IN MILD COGNITIVE IMPAIRMENT | $355,686 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | MEMORY T CELL DEVELOPMENT AND SURVIVAL IN T CELL RESPONSES OF OLDER INDIVIDUALS | $351,676 |
| 2020 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | INTESTINAL LYMPHOCYTE TRAFFICKING | $347,250 |
| 2020 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NEURAL IMMUNOREGULATION OF POST-TRAUMATIC AUTOIMMUNITY | $335,881 |
| 2020 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EFFICACY OF TWICE WEEKLY HEMODIALYSIS IN PATIENTS WITH RESIDUAL KIDNEY FUNCTION | $315,689 |
| 2020 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | TGF SIGNALING AS A NOVEL THERAPEUTIC TARGET FOR MILD TRAUMATIC BRAIN INJURY | $299,544 |
| 2020 | Department of the Army | Grant or other assistance | MILITARY MEDICAL RESEARCH AND DEVELOPMENT 12.420 | NEW AWARD - TARGETING MITOCHONDRIAL ENERGY METABOLISM FOR SYMPTOMATIC IMPROVEMENTS IN GULF WAR ILLNESSES, SIGNED 4/15/2020, EFFECTIVE 7/1/2020, DISTRIBUTED 4/20 | $209,251 |
| 2020 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | LARGE-SCALE CHARACTERIZATION OF AUTOANTIBODY RESPONSES IN RHEUMATOID ARTHRITIS | -$9 |
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $35,854,131 | $33,029,388 | $19,146,651 | $8,037,033 | $25,318,301 | $10,144,436 | $1,480,336 | 203 | 7 |
| 2023 · Form 990 | ||||||||
| $31,646,627 | $34,355,201 | $17,246,189 | $5,216,039 | $23,286,921 | $7,728,039 | $1,242,422 | 248 | 0 |
| 2022 · Form 990 | ||||||||
| $30,503,398 | $30,736,665 | $20,719,365 | $7,994,977 | $21,413,596 | $8,615,163 | $1,170,537 | 248 | 0 |
| 2021 · Form 990 | ||||||||
| $29,922,772 | $29,764,131 | $15,643,008 | $8,173,020 | $19,234,972 | $10,623,749 | $659,362 | 248 | 0 |
| 2020 · Form 990 | ||||||||
| $29,400,012 | $28,118,941 | $15,189,973 | $7,998,827 | $24,470,355 | $4,876,898 | $968,578 | 273 | 0 |
| 2019 · Form 990 | ||||||||
| $29,572,642 | $31,188,918 | $12,982,406 | $6,717,129 | $23,851,668 | $5,633,108 | $574,094 | 280 | 13 |
| 2018 · Form 990 | ||||||||
| $31,059,629 | $30,708,326 | $12,525,941 | $8,333,598 | $24,186,247 | $6,782,472 | $588,822 | 299 | 11 |
| 2017 · Form 990 | ||||||||
| $28,157,044 | $28,466,853 | $12,338,139 | $7,982,295 | $23,485,362 | $4,589,866 | $538,681 | 309 | 10 |
| 2016 · Form 990 | ||||||||
| $28,240,385 | $27,685,878 | $13,757,503 | $8,291,105 | $22,428,354 | $5,764,860 | $618,300 | 313 | 12 |
| 2015 · Form 990 | ||||||||
| $28,219,973 | $26,886,139 | $10,945,542 | $7,769,621 | $23,247,661 | $4,963,804 | $526,954 | 338 | 9 |
| 2014 · Form 990 | ||||||||
| $27,288,665 | $26,508,261 | $9,968,460 | $6,436,655 | $24,433,121 | $2,839,296 | $514,694 | 331 | 4 |
| 2013 · Form 990 | ||||||||
| $24,249,138 | $24,309,655 | $8,621,232 | $5,661,245 | $22,064,702 | $2,134,015 | $448,074 | 291 | 0 |
| 2011 · Form 990 | ||||||||
| $25,258,558 | $24,563,589 | $8,704,349 | $5,373,086 | $22,113,731 | $3,129,846 | $550,234 | 280 | 0 |
| 2010 · Form 990 | ||||||||
| $24,209,478 | $24,566,326 | $7,396,378 | $4,684,832 | $21,308,922 | $2,886,432 | $530,552 | 0 | 0 |
| 2009 · Form 990 | ||||||||
| $22,440,772 | $21,826,849 | $7,639,401 | $5,038,478 | $20,115,173 | $2,290,408 | $498,777 | 0 | 0 |
Funders of this organization
54 grantors reported grants to this organization, $26,434,056 in all, tax years 2009 to 2025; the 25 largest shown (all 54). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| AMERICAN HEART ASSOCIATION INC | Public charity | Exact | 2015-2016, 2018-2020, 2022-2023 | 7 | $5,380,850 | 2023 | $1,144,580 | show |
| LEONA M & HARRY B HELMSLEY CHARITABLE TRUST | Private foundation | Fuzzy filed as “PALO ALTO VETERANS INSTITUTE FOR RESEARCH” | 2020-2024 | 9 | $3,904,620 | 2024 | $318,978 | show |
| EMORY UNIVERSITY | Public charity | Exact | 2009-2020 | 12 | $3,221,353 | 2020 | $213,474 | show |
| FOUNDATION FOR ATLANTA VETERANS EDUCATION AND RESEARCH INC | Public charity | Exact | 2013-2015, 2018, 2020-2023 | 8 | $1,899,239 | 2023 | $202,119 | show |
| JOHNS HOPKINS UNIVERSITY | DAF sponsor | Exact | 2009-2020, 2022-2024 | 15 | $1,395,075 | 2024 | $110,745 | show |
| VANDERBILT UNIVERSITY MEDICAL CENTER | Public charity | Exact | 2017-2024 | 8 | $1,379,672 | 2024 | $176,094 | show |
| WASHINGTON UNIVERSITY | DAF sponsor | Exact | 2012-2016, 2018-2020, 2024 | 9 | $935,855 | 2024 | $84,579 | show |
| BRANDEIS UNIVERSITY | DAF sponsor | Exact | 2012-2013, 2015-2021 | 9 | $620,925 | 2021 | $47,709 | show |
| TRUSTEES OF COLUMBIA UNIVERSITY | DAF sponsor | Exact | 2009, 2020-2021 | 3 | $515,550 | 2021 | $47,587 | show |
| RHEUMATOLOGY RESEARCH FOUNDATION | Public charity | Exact | 2013-2015 | 5 | $500,000 | 2015 | $225,000 | show |
| ALZHEIMERS DISEASE RESEARCH FOUNDATION | Public charity | Exact | 2016, 2018-2019 | 3 | $495,000 | 2019 | $172,500 | show |
| GORDON E AND BETTY I MOORE FOUNDATION | Private foundation | Fuzzy filed as “Palo Alto Veterans Institute for Research” | 2021 | 1 | $492,000 | 2021 | $492,000 | show |
| MAYO CLINIC | Public charity | Exact | 2011-2015 | 5 | $480,444 | 2015 | $126,605 | show |
| VANDERBILT UNIVERSITY | Public charity | Exact | 2011-2014 | 4 | $422,599 | 2014 | $90,333 | show |
| UNIVERSITY OF PITTSBURGH | Public charity | Exact | 2016-2022 | 7 | $405,195 | 2022 | $29,544 | show |
| MUSCULAR DYSTROPHY ASSOCIATION | Public charity | Exact | 2010, 2015-2018 | 5 | $368,371 | 2018 | $69,621 | show |
| PLASTIC SURGERY FOUNDATION | Public charity | Exact | 2018, 2020 | 2 | $310,000 | 2020 | $300,000 | show |
| ALZHEIMERS DISEASE AND RELATED DISORDERS ASSOCIATION INC | Public charity | Exact | 2012, 2014 | 2 | $300,000 | 2014 | $100,000 | show |
| YALE UNIVERSITY | DAF sponsor | Exact | 2012-2013, 2019-2020, 2022-2023 | 6 | $282,125 | 2023 | $100,010 | show |
| THE MEDICAL COLLEGE OF WISCONSIN INC | Public charity | Exact | 2021-2023 | 3 | $267,955 | 2023 | $65,943 | show |
| ARTHRITIS FOUNDATION INC | Public charity | Exact | 2010, 2013 | 2 | $240,000 | 2013 | $100,000 | show |
| UNIVERSITY OF SOUTHERN CALIFORNIA | DAF sponsor | Exact | 2023-2024 | 2 | $236,672 | 2024 | $225,947 | show |
| LuMind IDSC Foundation | Public charity | Exact | 2012, 2015 | 2 | $230,000 | 2015 | $115,000 | show |
| FRED HUTCHINSON CANCER CENTER | Public charity | Exact | 2022-2024 | 3 | $195,136 | 2024 | $146,125 | show |
| TRUSTEES OF BOSTON UNIVERSITY | Public charity | Exact | 2022-2024 | 3 | $178,082 | 2024 | $81,889 | show |
Similar organizations
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION INC | CA | H00 | $69,153,222 | $69,514,782 | DIRECTOR | $484,108 | Same NTEE code H00, revenue within 2x, same state |
| OLIVE VIEW UCLA EDUCATION AND RESEARCH INSTITUTE INC | CA | H00 | $9,289,670 | $8,952,774 | PSYCHOLOGIST | $167,500 | Same NTEE code H00, revenue within 5x, same state |
| OCEAN STATE RESEARCH INSTITUTE INC | RI | H00 | $8,345,540 | $8,048,515 | DATA SCIENTIST | $155,625 | Same NTEE code H00, revenue within 5x, similar mission |
| BOSTON VA RESEARCH INSTITUTE INC | MA | H00 | $15,893,775 | $14,923,968 | SR DIRECTOR OF PRECISION MEDICINE | $257,899 | Same NTEE code H00, revenue within 5x |
| GATEWAY FOR CANCER RESEARCH INC | IL | H00 | $9,653,289 | $11,190,912 | PRESIDENT & CEO (THROUGH MAY 2025) | $307,301 | Same NTEE code H00, revenue within 5x |
| BALTIMORE RESEARCH & EDUCATION FOUNDATION INC | MD | H00 | $7,666,542 | $5,275,077 | EXECUTIVE DIRECTOR | $264,562 | Same NTEE code H00, revenue within 5x |
| AMERICAN COLLEGE OF ENDOCRINOLOGY INC | FL | H00 | $10,450,383 | $11,535,553 | CEO (FROM MARCH '24) | $363,814 | Same NTEE code H00, revenue within 5x |
| NATIONAL ALOPECIA AREATA FOUNDATION | CA | H00 | $3,998,061 | $3,850,182 | President & CEO | $352,349 | Same NTEE code H00, revenue within 10x, same state |
| HAWAII HOSPITAL EDUCATION AND RESEARCH FOUNDATION | HI | H00 | $5,121,276 | $4,237,680 | PRESIDENT AND CEO | $639,983 | Same NTEE code H00, revenue within 10x |
| KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | KS | H00 | $6,457,272 | $5,872,619 | CHAIR | $432,727 | Same NTEE code H00, revenue within 10x |
| AOAC INTERNATIONAL | MD | H00 | $6,552,979 | $6,989,949 | EXECUTIVE DIRECTOR | $382,076 | Same NTEE code H00, revenue within 10x |
| SAINT MARYS FOUNDATION | MI | H00 | $5,508,872 | $3,805,775 | TRUSTEE; TRINITY GRAND RAPIDS PRES | $924,821 | Same NTEE code H00, revenue within 10x |
| PUBLIC HEALTH SOLUTIONS | NY | H00 | $271,155,237 | $266,920,783 | PRESIDENT AND CEO | $428,556 | Same NTEE code H00, revenue within 10x |
| STRAUB FOUNDATION | HI | H00 | $6,804,543 | $2,703,798 | Board of Director | $5,445,826 | Same NTEE code H00, revenue within 10x |
| WALTER J GATTI FOUNDATION INC | FL | H00 | $4,700,000 | $5,502,627 | PRESIDENT | $0 | Same NTEE code H00, revenue within 10x |
| CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH | CA | H00 | -$114,070 | $314,044 | Trustee | $0 | Same NTEE code H00, revenue differs more than 10x, same state |
| EAST BAY INSTITUTE FOR RESEARCH AND EDUCATION INC | CA | H00 | $1,669,761 | $1,583,838 | Executive Dir. | $121,480 | Same NTEE code H00, revenue differs more than 10x, same state |
| TOWER CANCER RESEARCH FOUNDATION | CA | H00 | $3,146,877 | $3,636,819 | EXECUTIVE DIRECTOR | $295,587 | Same NTEE code H00, revenue differs more than 10x, same state |
| HARVEY BASSETT CLARKE FOUNDATION | CA | H00 | $168,000 | $146,960 | President | $0 | Same NTEE code H00, revenue differs more than 10x, same state |
| VETERANS HEALTH RESEARCH INSTITUTE OF CENTRAL NEW YORK INC | NY | H00 | $1,559,517 | $1,461,849 | STATUTORY DI | $366,997 | Same NTEE code H00, revenue differs more than 10x, similar name |
| CARL J SHAPIRO INSTITUTE FOR EDUCATION & RESEARCH AT HARVARD | MA | H00 | $589,161 | $668,811 | TTEE (EXOFF) & CO-CHAIR (PRES BIDMC) | $1,683,657 | Same NTEE code H00, revenue differs more than 10x |
| INDIANA INSTITUTE FOR MEDICAL RESEARCH INC | IN | H00 | $1,036,657 | $1,441,523 | DIRECTOR | $448,530 | Same NTEE code H00, revenue differs more than 10x |
| IOWA CITY VA MEDICAL RESEARCH FOUNDATION | IA | H00 | $387,310 | $389,952 | CHAIR | $179,786 | Same NTEE code H00, revenue differs more than 10x, similar mission |
| CLINICAL RESEARCH FOUNDATION INC | KY | H00 | $499,292 | $337,354 | Executive Dir. | $64,151 | Same NTEE code H00, revenue differs more than 10x |
| CANCER RESEARCH FOUNDATION INC | NY | H00 | $14,723 | $3,673 | DIRECTOR | $0 | Same NTEE code H00, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $33,029,388 spent · pay $19,815,713 · grants $0 · events $125,574
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $14,241,584 | $11,836,977 | $2,404,607 | - | 43.1% | |
| Fees: other services | $5,050,394 | $4,959,741 | $90,653 | - | 15.3% | |
| Other (as described) | SUBRECIPIENTS | $4,387,176 | $4,387,176 | - | - | 13.3% |
| Other (as described) | RESEARCH MATERIAL COST | $2,164,917 | $2,164,730 | $187 | - | 6.6% |
| Other employee benefits | $1,902,193 | $1,550,405 | $351,788 | - | 5.8% | |
| Pay: officers, directors, trustees, key employees | $1,480,336 | - | $1,480,336 | - | 4.5% | |
| Payroll taxes | $1,183,323 | $912,057 | $271,266 | - | 3.6% | |
| Pension plan contributions | $1,008,277 | $826,625 | $181,652 | - | 3.1% | |
| Information technology | $363,888 | $167,300 | $196,588 | - | 1.1% | |
| Travel | $352,491 | $339,328 | $13,163 | - | 1.1% | |
| Depreciation and depletion | $221,702 | $221,702 | - | - | 0.7% | |
| All other expenses | $155,551 | $142,846 | $12,705 | - | 0.5% | |
| Office expenses | $126,145 | $115,281 | $10,864 | - | 0.4% | |
| Conferences, conventions and meetings | $125,574 | $94,449 | $31,125 | - | 0.4% | |
| Insurance | $83,527 | - | $83,527 | - | 0.3% | |
| Fees: accounting | $75,870 | - | $75,870 | - | 0.2% | |
| Other (as described) | EQUIPMENT MAINTENANCE | $48,227 | $48,227 | - | - | 0.1% |
| Fees: legal | $40,187 | $25,014 | $15,173 | - | 0.1% | |
| Other (as described) | OTHER PERSONNEL COST | $18,026 | - | $18,026 | - | 0.1% |
| Total | $33,029,388 | 100% |
2023 · Form 990 · $34,355,201 spent · pay $18,983,304 · grants $0 · events $170,001
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $13,951,113 | $11,533,728 | $2,417,385 | - | 40.6% | |
| Other (as described) | Subrecipients | $6,141,808 | $6,141,808 | - | - | 17.9% |
| Fees: other services | $4,743,768 | $4,651,688 | $92,080 | - | 13.8% | |
| Other (as described) | Research material cost | $2,587,654 | $2,587,654 | - | - | 7.5% |
| Other employee benefits | $1,703,528 | $1,288,834 | $414,694 | - | 5.0% | |
| Pay: officers, directors, trustees, key employees | $1,242,422 | $30,012 | $1,212,410 | - | 3.6% | |
| Payroll taxes | $1,143,058 | $889,727 | $253,331 | - | 3.3% | |
| Pension plan contributions | $943,183 | $753,957 | $189,226 | - | 2.7% | |
| Information technology | $512,952 | $290,254 | $222,698 | - | 1.5% | |
| Depreciation and depletion | $233,668 | $229,805 | $3,863 | - | 0.7% | |
| Travel or entertainment for public officials | $194,770 | $194,770 | - | - | 0.6% | |
| Travel | $193,980 | $175,406 | $18,574 | - | 0.6% | |
| Conferences, conventions and meetings | $170,001 | $129,304 | $40,697 | - | 0.5% | |
| All other expenses | $166,919 | $154,350 | $12,569 | - | 0.5% | |
| Office expenses | $108,834 | $100,389 | $8,445 | - | 0.3% | |
| Fees: accounting | $91,568 | - | $91,568 | - | 0.3% | |
| Insurance | $81,029 | - | $81,029 | - | 0.2% | |
| Other (as described) | Equipment maintenance | $76,765 | $76,518 | $247 | - | 0.2% |
| Fees: legal | $44,641 | $42,574 | $2,067 | - | 0.1% | |
| Other (as described) | Other personnel cost | $23,540 | $492 | $23,048 | - | 0.1% |
| Total | $34,355,201 | 100% |
2022 · Form 990 · $30,736,665 spent · pay $17,658,723 · grants $0 · events $182,898
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,959,047 | $10,883,312 | $2,075,735 | - | 42.2% | |
| Other (as described) | Subrecipients | $4,710,531 | $4,710,531 | - | - | 15.3% |
| Other (as described) | Other personnel cost | $2,808,254 | $2,721,247 | $87,007 | - | 9.1% |
| Other (as described) | Research material cost | $2,291,654 | $2,291,654 | - | - | 7.5% |
| Other employee benefits | $1,679,739 | $1,306,644 | $373,095 | - | 5.5% | |
| Fees: other services | $1,418,862 | $1,405,220 | $13,642 | - | 4.6% | |
| Pay: officers, directors, trustees, key employees | $1,170,537 | $42,905 | $1,127,632 | - | 3.8% | |
| Payroll taxes | $1,053,034 | $840,151 | $212,883 | - | 3.4% | |
| Pension plan contributions | $796,366 | $644,750 | $151,616 | - | 2.6% | |
| Information technology | $568,520 | $326,287 | $242,233 | - | 1.8% | |
| Depreciation and depletion | $252,780 | $245,052 | $7,728 | - | 0.8% | |
| Conferences, conventions and meetings | $182,898 | $154,867 | $28,031 | - | 0.6% | |
| All other expenses | $153,121 | $141,031 | $12,090 | - | 0.5% | |
| Travel | $144,970 | $128,871 | $16,099 | - | 0.5% | |
| Travel or entertainment for public officials | $144,391 | $144,391 | - | - | 0.5% | |
| Other (as described) | Equipment maintenance | $113,911 | $112,963 | $948 | - | 0.4% |
| Fees: accounting | $107,102 | - | $107,102 | - | 0.3% | |
| Insurance | $80,524 | - | $80,524 | - | 0.3% | |
| Office expenses | $52,179 | $43,338 | $8,841 | - | 0.2% | |
| Fees: legal | $48,245 | $47,832 | $413 | - | 0.2% | |
| Total | $30,736,665 | 100% |
2021 · Form 990 · $29,764,131 spent · pay $15,439,467 · grants $0 · events $174,612
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $11,918,033 | $9,763,324 | $2,154,709 | - | 40.0% | |
| Other (as described) | Subrecipients | $6,349,179 | $6,349,179 | - | - | 21.3% |
| Other (as described) | Other personnel cost | $2,790,556 | $2,701,916 | $88,640 | - | 9.4% |
| Other (as described) | Research material cost | $2,476,846 | $2,476,846 | - | - | 8.3% |
| Other employee benefits | $1,160,835 | $895,275 | $265,560 | - | 3.9% | |
| Fees: other services | $1,006,626 | $983,537 | $23,089 | - | 3.4% | |
| Payroll taxes | $955,584 | $732,241 | $223,343 | - | 3.2% | |
| Pension plan contributions | $745,653 | $568,423 | $177,230 | - | 2.5% | |
| Pay: officers, directors, trustees, key employees | $659,362 | $3,982 | $655,380 | - | 2.2% | |
| Information technology | $625,657 | $336,068 | $289,589 | - | 2.1% | |
| Depreciation and depletion | $260,002 | $246,910 | $13,092 | - | 0.9% | |
| Conferences, conventions and meetings | $174,612 | $138,431 | $36,181 | - | 0.6% | |
| All other expenses | $137,518 | $136,690 | $828 | - | 0.5% | |
| Travel or entertainment for public officials | $103,916 | $103,916 | - | - | 0.3% | |
| Other (as described) | Equipment maintenance | $97,285 | $95,708 | $1,577 | - | 0.3% |
| Fees: accounting | $85,520 | - | $85,520 | - | 0.3% | |
| Insurance | $69,139 | - | $69,139 | - | 0.2% | |
| Travel | $63,859 | $54,491 | $9,368 | - | 0.2% | |
| Office expenses | $50,385 | $42,185 | $8,200 | - | 0.2% | |
| Fees: legal | $33,564 | $9,905 | $23,659 | - | 0.1% | |
| Total | $29,764,131 | 100% |
2020 · Form 990 · $28,118,941 spent · pay $16,053,637 · grants $0 · events $202,833
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,179,694 | $9,666,107 | $2,513,587 | - | 43.3% | |
| Other (as described) | SUBRECIPIENTS | $3,953,428 | $3,953,428 | - | - | 14.1% |
| Other (as described) | RESEARCH MATERIAL COST | $2,774,868 | $2,774,868 | - | - | 9.9% |
| Other (as described) | OTHER PERSONNEL COST | $2,694,507 | $2,610,405 | $84,102 | - | 9.6% |
| Fees: other services | $1,122,648 | $1,050,898 | $71,750 | - | 4.0% | |
| Other employee benefits | $1,059,383 | $842,531 | $216,852 | - | 3.8% | |
| Payroll taxes | $1,024,361 | $773,352 | $251,009 | - | 3.6% | |
| Pay: officers, directors, trustees, key employees | $968,578 | $51,766 | $916,812 | - | 3.4% | |
| Pension plan contributions | $821,621 | $633,446 | $188,175 | - | 2.9% | |
| Information technology | $523,237 | $325,984 | $197,253 | - | 1.9% | |
| Depreciation and depletion | $273,587 | $258,434 | $15,153 | - | 1.0% | |
| Conferences, conventions and meetings | $202,833 | $172,610 | $30,223 | - | 0.7% | |
| Other (as described) | EQUIPMENT MAINTENANCE | $180,449 | $179,098 | $1,351 | - | 0.6% |
| All other expenses | $93,995 | $74,878 | $19,117 | - | 0.3% | |
| Fees: accounting | $87,911 | - | $87,911 | - | 0.3% | |
| Insurance | $56,345 | - | $56,345 | - | 0.2% | |
| Fees: legal | $42,537 | $9,164 | $33,373 | - | 0.2% | |
| Travel | $28,544 | $28,544 | - | - | 0.1% | |
| Office expenses | $23,123 | $20,508 | $2,615 | - | 0.1% | |
| Travel or entertainment for public officials | $7,292 | $7,292 | - | - | 0.0% | |
| Total | $28,118,941 | 100% |
2019 · Form 990 · $31,188,918 spent · pay $16,710,546 · grants $0 · events $202,985
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,675,404 | $10,103,792 | $2,571,612 | - | 40.6% | |
| Other (as described) | SUBRECIPIENTS | $4,498,639 | $4,498,639 | - | - | 14.4% |
| Other (as described) | OTHER PERSONNEL COST | $3,368,925 | $3,440,393 | -$71,468 | - | 10.8% |
| Other (as described) | RESEARCH MATERIAL COST | $2,971,718 | $2,971,657 | $61 | - | 9.5% |
| Other employee benefits | $1,595,142 | $1,285,264 | $309,878 | - | 5.1% | |
| Fees: other services | $1,554,731 | $1,428,379 | $126,352 | - | 5.0% | |
| Payroll taxes | $1,046,461 | $801,503 | $244,958 | - | 3.4% | |
| Pension plan contributions | $819,445 | $609,740 | $209,705 | - | 2.6% | |
| Information technology | $629,650 | $381,410 | $248,240 | - | 2.0% | |
| Pay: officers, directors, trustees, key employees | $574,094 | $51,766 | $522,328 | - | 1.8% | |
| Other (as described) | EQUIPMENT MAINTENANCE | $499,232 | $495,565 | $3,667 | - | 1.6% |
| Depreciation and depletion | $296,054 | $268,394 | $27,660 | - | 0.9% | |
| Conferences, conventions and meetings | $202,985 | $134,797 | $68,188 | - | 0.7% | |
| All other expenses | $121,684 | $93,956 | $27,728 | - | 0.4% | |
| Fees: accounting | $87,783 | - | $87,783 | - | 0.3% | |
| Travel or entertainment for public officials | $71,256 | $71,256 | - | - | 0.2% | |
| Travel | $59,592 | $51,714 | $7,878 | - | 0.2% | |
| Insurance | $55,582 | - | $55,582 | - | 0.2% | |
| Fees: legal | $39,978 | $2,378 | $37,600 | - | 0.1% | |
| Office expenses | $20,563 | $15,148 | $5,415 | - | 0.1% | |
| Total | $31,188,918 | 100% |
2018 · Form 990 · $30,708,326 spent · pay $16,171,484 · grants $0 · events $258,445
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,511,212 | $10,241,720 | $2,269,492 | - | 40.7% | |
| Other (as described) | SUBRECIPIENTS | $3,927,490 | $3,927,490 | - | - | 12.8% |
| Other (as described) | RESEARCH MATERIAL COST | $3,598,470 | $3,598,434 | $36 | - | 11.7% |
| Other (as described) | OTHER PERSONNEL COST | $2,797,295 | $2,790,196 | $7,099 | - | 9.1% |
| Fees: other services | $1,808,374 | $1,718,888 | $89,486 | - | 5.9% | |
| Other employee benefits | $1,271,214 | $1,103,343 | $167,871 | - | 4.1% | |
| Payroll taxes | $1,040,467 | $810,601 | $229,866 | - | 3.4% | |
| Pension plan contributions | $759,769 | $592,110 | $167,659 | - | 2.5% | |
| Pay: officers, directors, trustees, key employees | $588,822 | $51,443 | $537,379 | - | 1.9% | |
| Information technology | $576,527 | $427,522 | $149,005 | - | 1.9% | |
| Other (as described) | EQUIPMENT MAINTENANCE | $411,754 | $408,873 | $2,881 | - | 1.3% |
| Travel or entertainment for public officials | $280,122 | $280,122 | - | - | 0.9% | |
| Depreciation and depletion | $259,068 | $234,750 | $24,318 | - | 0.8% | |
| Conferences, conventions and meetings | $258,445 | $212,873 | $45,572 | - | 0.8% | |
| All other expenses | $235,994 | $186,400 | $49,594 | - | 0.8% | |
| Travel | $163,116 | $147,407 | $15,709 | - | 0.5% | |
| Fees: accounting | $96,540 | - | $96,540 | - | 0.3% | |
| Insurance | $49,704 | - | $49,704 | - | 0.2% | |
| Fees: legal | $38,423 | $8,138 | $30,285 | - | 0.1% | |
| Office expenses | $35,520 | $28,674 | $6,846 | - | 0.1% | |
| Total | $30,708,326 | 100% |
2017 · Form 990 · $28,466,853 spent · pay $17,110,839 · grants $0 · events $235,711
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $13,295,885 | $11,313,525 | $1,982,360 | - | 46.7% | |
| Other (as described) | RESEARCH MATERIAL COSTS | $3,177,903 | $3,177,716 | $187 | - | 11.2% |
| Other (as described) | SUBRECIPIENTS | $3,045,000 | $3,045,000 | - | - | 10.7% |
| Other employee benefits | $1,431,752 | $1,054,871 | $376,881 | - | 5.0% | |
| Other (as described) | PERSONNEL COST | $1,420,018 | $1,336,460 | $83,558 | - | 5.0% |
| Fees: other services | $1,396,308 | $968,997 | $427,311 | - | 4.9% | |
| Payroll taxes | $1,124,654 | $918,795 | $205,859 | - | 4.0% | |
| Pension plan contributions | $719,867 | $551,185 | $168,682 | - | 2.5% | |
| Pay: officers, directors, trustees, key employees | $538,681 | $48,371 | $490,310 | - | 1.9% | |
| Information technology | $494,769 | $304,161 | $190,608 | - | 1.7% | |
| Other (as described) | EQUIPMENT MAINTENANCE | $462,711 | $460,408 | $2,303 | - | 1.6% |
| Depreciation and depletion | $353,058 | $334,302 | $18,756 | - | 1.2% | |
| Conferences, conventions and meetings | $235,711 | $198,069 | $37,642 | - | 0.8% | |
| Travel or entertainment for public officials | $194,572 | $194,572 | - | - | 0.7% | |
| All other expenses | $178,406 | $157,972 | $20,434 | - | 0.6% | |
| Travel | $167,932 | $147,324 | $20,608 | - | 0.6% | |
| Fees: accounting | $94,175 | - | $94,175 | - | 0.3% | |
| Insurance | $49,412 | - | $49,412 | - | 0.2% | |
| Fees: legal | $46,316 | $8,837 | $37,479 | - | 0.2% | |
| Office expenses | $39,723 | $33,366 | $6,357 | - | 0.1% | |
| Total | $28,466,853 | 100% |
2016 · Form 990 · $27,685,878 spent · pay $16,118,014 · grants $0 · events $215,686
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,610,874 | $10,607,749 | $2,003,125 | - | 45.5% | |
| Other (as described) | Research Material Costs | $3,536,371 | $3,536,315 | $56 | - | 12.8% |
| Fees: other services | $2,068,077 | $1,580,252 | $487,825 | - | 7.5% | |
| Other (as described) | Subrecipients | $1,901,938 | $1,901,938 | - | - | 6.9% |
| Other (as described) | Personnel Cost | $1,764,967 | $1,639,256 | $125,711 | - | 6.4% |
| Other employee benefits | $1,207,453 | $1,092,600 | $114,853 | - | 4.4% | |
| Payroll taxes | $1,036,912 | $832,448 | $204,464 | - | 3.7% | |
| Pension plan contributions | $644,475 | $500,572 | $143,903 | - | 2.3% | |
| Pay: officers, directors, trustees, key employees | $618,300 | $29,948 | $588,352 | - | 2.2% | |
| All other expenses | $408,108 | $307,672 | $100,436 | - | 1.5% | |
| Depreciation and depletion | $403,272 | $396,978 | $6,294 | - | 1.5% | |
| Information technology | $348,757 | $225,906 | $122,851 | - | 1.3% | |
| Other (as described) | Equipment Maintenance | $339,168 | $338,337 | $831 | - | 1.2% |
| Conferences, conventions and meetings | $215,686 | $183,509 | $32,177 | - | 0.8% | |
| Travel | $192,332 | $176,995 | $15,337 | - | 0.7% | |
| Travel or entertainment for public officials | $185,752 | $185,752 | - | - | 0.7% | |
| Fees: accounting | $93,515 | - | $93,515 | - | 0.3% | |
| Insurance | $42,557 | - | $42,557 | - | 0.2% | |
| Office expenses | $35,724 | $25,774 | $9,950 | - | 0.1% | |
| Fees: legal | $31,640 | $6,841 | $24,799 | - | 0.1% | |
| Total | $27,685,878 | 100% |
2015 · Form 990 · $26,886,139 spent · pay $15,765,025 · grants $0 · events $203,735
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $12,496,177 | $10,543,634 | $1,952,543 | - | 46.5% | |
| Other (as described) | Research Material Costs | $3,833,775 | $3,833,682 | $93 | - | 14.3% |
| Other (as described) | Subrecipients | $1,752,243 | $1,752,243 | - | - | 6.5% |
| Other (as described) | Personnel Cost | $1,725,408 | $1,595,400 | $130,008 | - | 6.4% |
| Fees: other services | $1,561,317 | $1,123,630 | $437,687 | - | 5.8% | |
| Other employee benefits | $1,083,546 | $905,314 | $178,232 | - | 4.0% | |
| Payroll taxes | $1,039,105 | $853,896 | $185,209 | - | 3.9% | |
| Pension plan contributions | $619,243 | $486,133 | $133,110 | - | 2.3% | |
| Pay: officers, directors, trustees, key employees | $526,954 | - | $526,954 | - | 2.0% | |
| Information technology | $433,715 | $241,097 | $192,618 | - | 1.6% | |
| Depreciation and depletion | $424,076 | $412,292 | $11,784 | - | 1.6% | |
| Other (as described) | Equipment Maintenance | $417,580 | $416,662 | $918 | - | 1.6% |
| Conferences, conventions and meetings | $203,735 | $173,184 | $30,551 | - | 0.8% | |
| All other expenses | $198,222 | $147,649 | $50,573 | - | 0.7% | |
| Travel | $158,771 | $145,663 | $13,108 | - | 0.6% | |
| Travel or entertainment for public officials | $144,562 | $144,562 | - | - | 0.5% | |
| Fees: accounting | $109,392 | - | $109,392 | - | 0.4% | |
| Office expenses | $73,273 | $32,262 | $41,011 | - | 0.3% | |
| Insurance | $43,955 | - | $43,955 | - | 0.2% | |
| Fees: legal | $41,090 | $10,034 | $31,056 | - | 0.2% | |
| Total | $26,886,139 | 100% |
2014 · Form 990 · $26,508,261 spent · pay $15,153,604 · grants $0 · events $195,181
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $11,846,056 | $10,353,754 | $1,492,302 | - | 44.7% | |
| Other (as described) | RESEARCH MATERIAL COSTS | $3,671,789 | $3,671,789 | - | - | 13.9% |
| Other (as described) | SUBRECIPIENTS | $1,927,433 | $1,927,433 | - | - | 7.3% |
| Fees: other services | $1,709,712 | $1,199,813 | $509,899 | - | 6.4% | |
| Other (as described) | PERSONNEL COST | $1,624,088 | $1,489,095 | $134,993 | - | 6.1% |
| Other employee benefits | $1,254,343 | $1,043,100 | $211,243 | - | 4.7% | |
| Payroll taxes | $952,629 | $808,749 | $143,880 | - | 3.6% | |
| Information technology | $603,417 | $382,619 | $220,798 | - | 2.3% | |
| Pension plan contributions | $585,882 | $529,367 | $56,515 | - | 2.2% | |
| Pay: officers, directors, trustees, key employees | $514,694 | - | $514,694 | - | 1.9% | |
| Other (as described) | EQUIPMENT RENTAL & MAIN | $443,185 | $439,894 | $3,291 | - | 1.7% |
| Depreciation and depletion | $324,047 | $312,266 | $11,781 | - | 1.2% | |
| All other expenses | $234,133 | $213,698 | $20,435 | - | 0.9% | |
| Travel | $213,358 | $195,146 | $18,212 | - | 0.8% | |
| Conferences, conventions and meetings | $195,181 | $152,522 | $42,659 | - | 0.7% | |
| Travel or entertainment for public officials | $119,005 | $119,005 | - | - | 0.4% | |
| Office expenses | $107,270 | $41,929 | $65,341 | - | 0.4% | |
| Fees: accounting | $101,200 | - | $101,200 | - | 0.4% | |
| Insurance | $40,669 | - | $40,669 | - | 0.2% | |
| Fees: legal | $40,170 | $3,287 | $36,883 | - | 0.2% | |
| Total | $26,508,261 | 100% |
2013 · Form 990 · $24,309,655 spent · pay $13,407,114 · grants $0 · events $239,547
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $10,504,114 | $9,134,326 | $1,369,788 | - | 43.2% | |
| Other (as described) | RESEARCH MATERIAL COSTS | $3,106,032 | $3,103,689 | $2,343 | - | 12.8% |
| Fees: other services | $2,201,564 | $1,776,163 | $425,401 | - | 9.1% | |
| Other (as described) | PERSONNEL COST | $1,709,950 | $1,539,164 | $170,786 | - | 7.0% |
| Other (as described) | SUBRECIPIENTS | $1,580,255 | $1,580,255 | - | - | 6.5% |
| Other employee benefits | $1,145,761 | $977,437 | $168,324 | - | 4.7% | |
| Payroll taxes | $713,224 | $603,019 | $110,205 | - | 2.9% | |
| Information technology | $655,222 | $310,474 | $344,748 | - | 2.7% | |
| Pension plan contributions | $595,941 | $481,502 | $114,439 | - | 2.5% | |
| Pay: officers, directors, trustees, key employees | $448,074 | - | $448,074 | - | 1.8% | |
| Other (as described) | EQUIPMENT RENTAL & MAIN | $414,653 | $406,937 | $7,716 | - | 1.7% |
| Conferences, conventions and meetings | $239,547 | $207,585 | $31,962 | - | 1.0% | |
| Depreciation and depletion | $227,531 | $220,981 | $6,550 | - | 0.9% | |
| Travel or entertainment for public officials | $186,382 | $186,382 | - | - | 0.8% | |
| All other expenses | $181,621 | $170,290 | $11,331 | - | 0.7% | |
| Travel | $139,537 | $127,458 | $12,079 | - | 0.6% | |
| Fees: accounting | $85,700 | - | $85,700 | - | 0.4% | |
| Office expenses | $73,433 | $60,637 | $12,796 | - | 0.3% | |
| Fees: legal | $62,925 | $478 | $62,447 | - | 0.3% | |
| Insurance | $38,189 | - | $38,189 | - | 0.2% | |
| Total | $24,309,655 | 100% |
2011 · Form 990 · $24,563,589 spent · pay $13,708,115 · grants $0 · events $180,138
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $10,819,303 | $9,280,612 | $1,538,691 | - | 44.0% | |
| Fees: other services | $4,302,110 | $3,797,747 | $504,363 | - | 17.5% | |
| Other (as described) | RESEARCH MATERIAL COSTS | $2,648,385 | $2,648,250 | $135 | - | 10.8% |
| Other (as described) | PERSONNEL COST | $2,157,909 | $2,008,681 | $149,228 | - | 8.8% |
| Payroll taxes | $912,756 | $754,313 | $158,443 | - | 3.7% | |
| Other employee benefits | $858,747 | $723,754 | $134,993 | - | 3.5% | |
| Pension plan contributions | $567,075 | $451,397 | $115,678 | - | 2.3% | |
| Pay: officers, directors, trustees, key employees | $550,234 | - | $550,234 | - | 2.2% | |
| Information technology | $371,402 | $181,827 | $189,575 | - | 1.5% | |
| Other (as described) | EQUIPMENT RENTAL & MAIN | $320,285 | $308,590 | $11,695 | - | 1.3% |
| Depreciation and depletion | $184,052 | - | $184,052 | - | 0.7% | |
| Conferences, conventions and meetings | $180,138 | $152,122 | $28,016 | - | 0.7% | |
| Travel | $147,504 | $138,389 | $9,115 | - | 0.6% | |
| Travel or entertainment for public officials | $143,091 | $143,091 | - | - | 0.6% | |
| Other (as described) | RESEARCH SUBJECT COST | $128,462 | $128,462 | - | - | 0.5% |
| Fees: accounting | $88,800 | - | $88,800 | - | 0.4% | |
| Insurance | $53,647 | - | $53,647 | - | 0.2% | |
| All other expenses | $48,156 | $40,195 | $7,961 | - | 0.2% | |
| Office expenses | $46,974 | $34,490 | $12,484 | - | 0.2% | |
| Fees: legal | $34,559 | - | $34,559 | - | 0.1% | |
| Total | $24,563,589 | 100% |
2010 · Form 990 · $24,566,326 spent · pay $12,997,733 · grants $0 · events $155,344
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $10,188,608 | $8,802,243 | $1,386,365 | - | 41.5% | |
| Fees: other services | $4,547,455 | $3,741,424 | $806,031 | - | 18.5% | |
| Other (as described) | RESEARCH MATERIAL COSTS | $2,887,777 | $2,887,697 | $80 | - | 11.8% |
| Other (as described) | PERSONNEL COST | $2,373,924 | $2,231,740 | $142,184 | - | 9.7% |
| Other employee benefits | $879,182 | $728,053 | $151,129 | - | 3.6% | |
| Payroll taxes | $875,506 | $730,397 | $145,109 | - | 3.6% | |
| Pay: officers, directors, trustees, key employees | $530,552 | - | $530,552 | - | 2.2% | |
| Pension plan contributions | $523,885 | $431,017 | $92,868 | - | 2.1% | |
| Information technology | $463,988 | $205,379 | $258,609 | - | 1.9% | |
| Other (as described) | EQUIP. RENTAL & MAINT. | $344,115 | $340,953 | $3,162 | - | 1.4% |
| Depreciation and depletion | $188,106 | - | $188,106 | - | 0.8% | |
| Conferences, conventions and meetings | $155,344 | $122,743 | $32,601 | - | 0.6% | |
| Other (as described) | RESEARCH SUBJECT COST | $131,231 | $131,231 | - | - | 0.5% |
| Travel | $130,094 | $113,084 | $17,010 | - | 0.5% | |
| Travel or entertainment for public officials | $115,725 | $115,725 | - | - | 0.5% | |
| Fees: accounting | $84,932 | - | $84,932 | - | 0.3% | |
| Office expenses | $60,406 | $42,511 | $17,895 | - | 0.2% | |
| Other (as described) | POSTAGE AND OTHER | $39,044 | $29,693 | $9,351 | - | 0.2% |
| Fees: legal | $23,440 | - | $23,440 | - | 0.1% | |
| Insurance | $23,012 | - | $23,012 | - | 0.1% | |
| Total | $24,566,326 | 100% |
2009 · Form 990 · $21,826,849 spent · pay $11,412,899 · grants $0 · events $139,477
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $8,874,610 | $7,609,449 | $1,265,161 | - | 40.7% | |
| Fees: other services | $3,659,505 | $2,903,437 | $756,068 | - | 16.8% | |
| Other (as described) | Research Material Costs | $2,785,430 | $2,785,430 | - | - | 12.8% |
| Other (as described) | personnel cost | $2,487,144 | $2,369,508 | $117,636 | - | 11.4% |
| Other employee benefits | $767,370 | $690,523 | $76,847 | - | 3.5% | |
| Payroll taxes | $753,831 | $616,113 | $137,718 | - | 3.5% | |
| Pension plan contributions | $518,311 | $428,697 | $89,614 | - | 2.4% | |
| Pay: officers, directors, trustees, key employees | $498,777 | - | $498,777 | - | 2.3% | |
| Information technology | $358,408 | $193,519 | $164,889 | - | 1.6% | |
| Other (as described) | Equip. Rental & Maint. | $239,204 | $236,402 | $2,802 | - | 1.1% |
| Depreciation and depletion | $165,635 | - | $165,635 | - | 0.8% | |
| Other (as described) | research subject cost | $140,887 | $140,887 | - | - | 0.6% |
| Conferences, conventions and meetings | $139,477 | $115,183 | $24,294 | - | 0.6% | |
| Travel | $128,819 | $115,672 | $13,147 | - | 0.6% | |
| Travel or entertainment for public officials | $125,750 | $125,750 | - | - | 0.6% | |
| Fees: accounting | $81,827 | - | $81,827 | - | 0.4% | |
| Office expenses | $59,343 | $39,252 | $20,091 | - | 0.3% | |
| Insurance | $19,017 | - | $19,017 | - | 0.1% | |
| Other (as described) | Postage and other | $16,509 | $8,805 | $7,704 | - | 0.1% |
| Fees: legal | $6,995 | $4,700 | $2,295 | - | 0.0% | |
| Total | $21,826,849 | 100% |